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SUMMARY 37 
The use of alternative translation initiation sites enables production of more 38 
than one protein from a single gene, thereby expanding cellular proteome. 39 
Although several such examples have been serendipitously found in bacteria, 40 
genome-wide mapping of alternative translation start sites has been unattainable. 41 
We found that the antibiotic retapamulin specifically arrests initiating ribosomes at 42 
start codons of the genes. Retapamulin-enhanced Ribo-seq analysis (Ribo-RET) 43 
not only allowed mapping of conventional initiation sites at the beginning of the 44 
genes but, strikingly, it also revealed putative internal start sites in a number of 45 
Escherichia coli genes. Experiments demonstrated that the internal start codons 46 
can be recognized by the ribosomes and direct translation initiation in vitro and in 47 
vivo. Proteins, whose synthesis is initiated at an internal in-frame and out-of-frame 48 
start sites, can be functionally important and contribute to the ‘alternative’ bacterial 49 
proteome. The internal start sites may also play regulatory roles in gene 50 
expression. 51 
  52 
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INTRODUCTION  53 
A broader diversity of proteins with specialized functions can augment cell 54 
reproduction capacity, optimize its metabolism, and facilitate survival in the ever-55 
changing environment. However, the fitness gain acquired by making a new 56 
protein is counterbalanced with the cost of expanding the size of the genome, a 57 
conundrum particularly onerous in bacteria whose genomes are highly 58 
streamlined.  59 
Different strategies can be used for diversifying proteome without 60 
expanding genome size. For instance, ribosomes may initiate at a unique start 61 
codon of an open reading frame (ORF), but due to programmed ribosomal 62 
frameshifting or stop codon readthrough, some of them may produce a polypeptide 63 
whose sequence deviates from that encoded in the main ORF. Such recoding 64 
events lead to generation of more than one protein from a single gene (Atkins et 65 
al., 2016; Baranov et al., 2015).  66 
Another possible way for producing diverse polypeptides from a single ORF 67 
is the utilization of alternative internally located start codons. Although translation 68 
of the majority of the bacterial genes is initiated at a unique TIS, designated herein 69 
as primary (pTIS), several examples of genes with an additional internal TIS (iTIS) 70 
have been uncovered by detecting additional polypeptide products during the 71 
purification of the primary protein (reviewed in (Meydan et al., 2018)). In these 72 
genes, translation initiated at the pTIS results in production of the full-length 73 
(primary) protein, while ribosomes that initiate translation at the in-frame iTIS 74 
synthesize an alternative, N-terminally truncated polypeptide. Such primary and 75 
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alternative proteins may have related but specialized functions. The products of in-76 
frame internal initiation at several bacterial genes have been reported to participate 77 
in various cellular functions ranging from virulence, to photosynthesis, or antibiotic 78 
production among others (reviewed in (Meydan et al., 2018)). In very few known 79 
cases, iTIS directs translation in a reading frame different from the primary ORF 80 
(D'Souza et al., 1994; Feltens et al., 2003; Yuan et al., 2018).  81 
Most of the known examples of translation of a protein from an iTIS have 82 
been discovered serendipitously. Although several computational algorithms can 83 
predict the pTIS of many bacterial ORFs (Gao et al., 2010; Giess et al., 2017; 84 
Makita et al., 2007; Salzberg et al., 1998), iTIS prediction remains by far more 85 
challenging and has not even been pursued in most of those studies. The recent 86 
advent of new mass-spectrometry-based approaches have allowed the 87 
identification of N-terminal peptides of a range of proteins expressed in bacteria 88 
(Bienvenut et al., 2015; Impens et al., 2017), including some whose translation 89 
was likely initiated at an iTIS.  However, the success of the available techniques 90 
for identifying such proteins is intrinsically restricted by the stringent requirements 91 
for the chemical properties, size, and abundance of the peptides that can be 92 
detected by mass-spectrometry. Therefore, the majority of the functional iTISs in 93 
the genomes likely remain overlooked. 94 
Ribosome profiling (Ribo-seq), based on deep sequencing of ribosome 95 
protected mRNA fragments (“ribosome footprints”), allows for genome-wide survey 96 
of translation (Ingolia et al., 2009). Ribo-seq experiments carried out with 97 
eukaryotic cells pre-treated with the translation initiation inhibitors harringtonine 98 
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(Ingolia et al., 2011) and lactimidomycin (Gao et al., 2015; Lee et al., 2012) or with 99 
puromycin (Fritsch et al., 2012), showed specific enrichment of ribosome footprints 100 
at or near start codons of ORFs and facilitated mapping of TISs in eukaryotic 101 
genomes. These studies also revealed active translation of previously unknown 102 
short ORFs in the 5’ UTRs of many genes and identified several TISs within the 103 
genes that were attributed to leaky scanning through the primary start sites (Lee 104 
et al., 2012). Analogous studies, however, have been difficult to conduct in bacteria 105 
because of the paucity of inhibitors with the required mechanism of action. An 106 
inhibitor useful for mapping start sites should allow the assembly of the 70S 107 
translation initiation complex at a TIS but must prevent the ribosome from leaving 108 
the start codon. Unfortunately, most of the ribosomal antibiotics traditionally viewed 109 
as initiation inhibitors do not satisfy these criteria. Recently, tetracycline (TET), an 110 
antibiotic that prevents aminoacyl-tRNAs from entering the ribosomal A site and 111 
commonly known as an elongation inhibitor (Cundliffe, 1981), was used in 112 
conjunction with Ribo-seq to globally map pTISs in the E. coli genome 113 
(Nakahigashi et al., 2016). Although TET Ribo-seq data successfully revealed the 114 
pTISs of many of the actively translated genes, identification of iTISs was not 115 
feasible in that work because of the substantial number of footprints generated by 116 
elongating ribosomes. Furthermore, because TET can potentially bind to the 117 
ribosome at every round of elongation cycle, when the A-site is temporarily empty, 118 
it is impossible to distinguish whether the footprints within the ORFs represented 119 
elongating ribosomes or those initiating translation at an iTIS (Nakahigashi et al., 120 
2016).  121 
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Here we show that retapamulin (RET), an antibiotic of the pleuromutilin 122 
family, exclusively stalls ribosomes at the start codons of the ORFs. Brief pre-123 
treatment of E. coli cells with RET dramatically rearranges the distribution of 124 
ribosomes along the ORFs, confining the ribosomal footprints obtained by Ribo-125 
seq to the TISs of the genes. Strikingly, the application of the Ribo-seq/RET 126 
approach to the analysis of bacterial translation revealed that more than many E. 127 
coli genes contain actively used iTISs. In vitro and in vivo experiments confirmed 128 
initiation of translation at some of the discovered iTISs and show that internal 129 
initiation may lead to production of proteins with distinct functions. Our data show 130 
that initiation at alternative start sites is widespread in bacteria and reveal the 131 
possible existence of a previously cryptic fraction of the proteome. 132 
 133 
RESULTS  134 
RET arrests the initiating ribosome at the start codons  135 
Pleuromutilin antibiotics, including clinically-used semi-synthetic RET, bind in the 136 
peptidyl transferase center (PTC) of the bacterial ribosome, hindering the 137 
placement of the P- and A-site amino acids and thus preventing peptide bond 138 
formation (Figure S1A and S1B) (Davidovich et al., 2007; Poulsen et al., 2001; 139 
Schlunzen et al., 2004). In vitro studies have shown that presence of fMet-tRNA 140 
and RET in the ribosome are not mutually exclusive (Yan et al., 2006). Therefore, 141 
we reasoned that RET may allow the assembly of the 70S initiation complex at the 142 
start codon, but by displacing the aminoacyl moiety of the initiator fMet-tRNA and 143 
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interfering with the placement of an elongator aminoacyl-tRNA in the A site, it could 144 
prevent formation of the first peptide bond.  145 
The results of polysome analysis were compatible with RET being a 146 
selective translation initiation inhibitor, because treatment of E. coli cells with high 147 
concentrations of the drug, 100-fold over the minimal inhibitory concentration 148 
(MIC), rapidly converted polysomes into monosomes (Figure S1C). We then used 149 
toeprinting analysis ((Hartz et al., 1988) to test whether RET captures ribosomes 150 
at start codons. When model genes were translated in an E. coli cell-free system 151 
(Shimizu et al., 2001), addition of RET stalled ribosomes exclusively at the ORFs 152 
start codons (Figure 1A, ‘RET’ lanes), demonstrating that this antibiotic readily, 153 
and possibly specifically, inhibits translation initiation. In contrast, TET, which was 154 
used previously to map TISs in the E. coli genome (Nakahigashi et al., 2016), 155 
halted translation not only at the translation initiation sites but also at downstream 156 
codons of the ORFs (Figure 1A, ‘TET’ lanes), confirming that this inhibitor 157 
interferes with both initiation and elongation of translation (Orelle et al., 2013). 158 
The outcomes of the polysome- and toeprinting analyses, along with the 159 
structural data showing the incompatibility of the nascent protein chain with RET 160 
binding (Figure S1B), encouraged us to assess whether RET would enable the 161 
use of Ribo-seq for mapping translation start sites in bacterial cells. Even a brief 162 
(2 min) exposure of the 'tolC derivative of the E. coli strain BW25113 to a 32-fold 163 
MIC of RET nearly completely halts protein synthesis (Figure S1D). However, in 164 
Ribo-seq experiments we exposed cells for 5 min to a 100-fold MIC of RET to 165 
ensure that elongating ribosomes complete translation of even long or slowly-166 
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translated ORFs prior to cell harvesting. Analysis of the Ribo-seq data showed that 167 
the RET treatment led to a striking ribosome redistribution. The occupancy of the 168 
internal and termination codons of the expressed genes was severely reduced 169 
compared to that of the untreated control, whereas the ribosome density peaks at 170 
the start codons dramatically increased (Figure 1B and 1C). Although a generally 171 
similar trend can be observed in the metagene analysis of the Ribo-seq data in the 172 
RET- (this paper) and TET-treated cells (Nakahigashi et al., 2016), the start-173 
codons peak in the TET experiments is smaller and broader compared to the peak 174 
of the RET-stalled ribosomes (Figure S1E and S1F), reflecting a higher potency of 175 
RET as initiation inhibitor. Filtered by fairly conservative criteria (see STAR 176 
Methods), Ribo-seq data revealed distinct peaks of ribosome density at the 177 
annotated start codons (pTISs) of 991 out of 1153 (86%) E. coli genes expressed 178 
in the BW25113. The magnitude of the start codon peaks at the remaining 14% of 179 
the translated genes did not pass our threshold criteria (see STAR Methods) 180 
possibly reflecting changes in gene expression due to the RET treatment. 181 
Taken together, our in vitro and in vivo results showed that RET acts as a 182 
specific inhibitor of translation initiation locking the ribosomes at the start codons, 183 
and in combination with Ribo-seq can be used for mapping the pTISs of the 184 
majority of actively translated genes in bacterial genomes. We named the Ribo-185 
seq/RET approach ‘Ribo-RET’. 186 
 187 
Ribo-RET unmasks initiation of translation at internal codons of many 188 
bacterial genes  189 
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Even though the majority of the ribosome footprints in the Ribo-RET dataset 190 
mapped to annotated pTISs, we also observed peaks at certain internal codons 191 
(Figure 2A). Hypothetically, the presence of internal Ribo-RET peaks could be 192 
explained by elongating ribosomes paused at specific sites within the ORF. 193 
Nonetheless, this possibility seems unlikely, since no substantial Ribo-RET peak 194 
was detected even at the most prominent programmed translation arrest site in the 195 
E. coli genome within the secM ORF (Nakatogawa and Ito, 2002) (Figure S1G). 196 
Similarly implausible was the origin of the internal RET peaks from context-specific 197 
elongation arrest observed with some other antibiotics (Kannan et al., 2014; Marks 198 
et al., 2016) because biochemical (Dornhelm and Hogenauer, 1978) and structural 199 
(Davidovich et al., 2007) data strongly argue that RET cannot bind to the 200 
elongating ribosome (Figure S1B). We therefore concluded that the Ribo-RET 201 
peaks at internal sites within ORFs must represent ribosomes caught in the act of 202 
initiating translation.  203 
Three E. coli genes, infB, mcrB and clpB, were previously reported to 204 
encode two different polypeptide isoforms due to the iTIS presence: translation of 205 
the full-size protein is initiated at the pTIS while the shorter isoform is expressed 206 
from an iTIS (Broome-Smith et al., 1985; Park et al., 1993; Plumbridge et al., 1985). 207 
The Ribo-RET profile of these genes showed well-defined and highly-specific 208 
ribosome density peaks (Figure 2B) at the known iTISs, thereby verifying the utility 209 
of Ribo-RET for mapping iTISs in bacterial genes.  210 
Among the E. coli BW25113 genes expressed in our conditions, we 211 
identified 239 iTIS candidates. To further expand the systematic identification of 212 
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iTISs in E. coli genes, we applied the Ribo-RET approach to the 'tolC derivative 213 
of the E. coli strain BL21, a B-type strain which is genetically distinct from the K-214 
strain BW25113 (Grenier et al., 2014; Studier et al., 2009). Ribo-RET analysis 215 
identified 620 iTISs in the BL21 strain. Of these, 124 iTISs were common between 216 
the two strains (Table S1). While a notably higher number of iTIS in the BL21 217 
remains somewhat puzzling, it may be related to the fact that more genes are 218 
expressed in this strain in comparison with BW25113 (1990 genes with the 219 
identified pTISs in BL21 strain vs 1554 such genes in BW25113), and to the 220 
sequence variations between the strains, as a result of which 244 BL21-specific 221 
iTISs did not have a perfect sequence match in the BW25113 strain. We limited 222 
our subsequent analysis to 124 iTISs conserved between the two strains, among 223 
which, 42 directed translation in frame with the main gene, whereas start codons 224 
of 74 iTISs were out of frame relative to the main ORF; for 8 iTISs the start site 225 
was not assigned (Figure 2C and Table S1). In the following sections we consider 226 
the first two classes separately. 227 
 228 
Internal translation initiation sites that are in frame with the main ORF 229 
The in-frame iTISs exploit various initiator codons that have been shown previously 230 
to be capable of directing translation initiation in E. coli (Chengguang et al., 2017; 231 
Hecht et al., 2017), although similar to the pTISs, the AUG codon is the most 232 
prevalent (Figure 3A). A SD-like sequence could be recognized upstream of many 233 
of the in-frame internal start codons (Table S1).  234 
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Initiation at an in-frame iTIS would generate an N-terminally truncated form 235 
of the primary protein. The sizes of candidate proteins expressed from in-frame 236 
iTISs range from 6 to 805 amino acids in length (Table S1). Although the locations 237 
of in-frame iTISs are highly variable, the majority are clustered close to the 238 
beginning of the gene or are within the 3’ terminal quartile of the ORF length 239 
(Figure 3B). We examined the iTIS of the arcB gene as a 3’-proximal start site 240 
representative and that of speA as an example of the 5’-proximal iTIS. 241 
 242 
A protein with a putative specialized function is translated from the 3’-243 
proximal iTIS of the arcB gene 244 
The gene arcB encodes the sensor kinase ArcB of the two-component 245 
signal transduction system ArcB/A that helps bacteria to sense and respond to 246 
changes in oxygen concentration (Alvarez and Georgellis, 2010) (Figure 3C and 247 
3D). The ArcB protein consists of the transmitter, receiver and phosphotransfer 248 
domains (Figure 3D). Under microaerobic conditions, ArcB undergoes a series of 249 
phosphorylation steps that eventually activate the response regulator ArcA that 250 
controls expression of nearly 200 genes (Alvarez and Georgellis, 2010; Salmon et 251 
al., 2005). The C-terminal ArcB-C domain is the ultimate receiver of the phosphoryl 252 
group within the ArcB membrane-anchored protein and serves as the phosphoryl 253 
donor for ArcA (Alvarez et al., 2016).  254 
The Ribo-RET data showed a strong ribosome density peak at an iTIS in 255 
arcB, with the putative start codon GUG located precisely at the 5’ boundary of the 256 
segment encoding the ArcB-C domain (Figure 3C, D). A similarly located iTIS can 257 
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be found in the arcB gene of several bacterial species (Figure S2B). Initiation of 258 
translation at the arcB iTIS could generate a diffusible ArcB-C polypeptide, 259 
detached from the membrane-bound ArcB kinase (Figure 3D). To test this 260 
possibility, we introduced the 3xFLAG-coding sequence at the 3’ end of the arcB 261 
gene, expressed it from a plasmid in E. coli cells and analyzed the protein products. 262 
Expression of the tagged arcB resulted in the simultaneous production of the full-263 
size ArcB and of a smaller protein with apparent molecular weight (MW) of 14 kDa, 264 
consistent with that of the FLAG-tagged ArcB-C (Figures 3E and S2A). Disruption 265 
of the iTIS by synonymous mutations did not affect the synthesis of the full-length 266 
ArcB but abrogated that of ArcB-C (Figure 3E) confirming that the ArcB-C 267 
polypeptide is produced via initiation of translation at the arcB iTIS. Previous in 268 
vitro experiments showed that the isolated ArcB-C domain could serve as a 269 
phosphoryl acceptor and donor for the ArcB-catalyzed phosphorylation reactions 270 
(Alvarez and Georgellis, 2010), suggesting that a self-standing ArcB-C protein is 271 
likely functional in vivo. In agreement with this possibility, under micro-aerobic 272 
conditions E. coli cells with the operational arcB iTIS win over the mutant in which 273 
the iTIS is disrupted by synonymous mutations (Figures 3F and S2C). Diffusible 274 
ArcB-C may either facilitate the operation of the ArcB-ArcA signal transduction 275 
pathway or could enable a cross-talk with other signal transduction systems 276 
(Figure 3G).  277 
The expression of ArcB-C from the arcB iTIS is apparently quite efficient 278 
because E. coli and Salmonella enterica Ribo-seq datasets show a notable upshift 279 
in the ribosome density at the arcB codons located downstream from the iTIS 280 
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(Baek et al., 2017; Kannan et al., 2014; Li et al., 2014) (Figure S2D-S2G). 281 
Curiously, the average ribosome occupancy of the arcB codons before and after 282 
the iTIS vary under different physiological conditions (Figure S2F and S2G), 283 
suggesting that utilization of the arcB pTIS and iTIS could be regulated. 284 
Another remarkable example of in-frame 3’-proximal iTISs is found in the 285 
homologous rpnA-E genes of E. coli, encoding nucleases involved in DNA 286 
recombination (Kingston et al., 2017). Each of the rpn genes show Ribo-RET 287 
peaks at iTISs that appear to be their major initiation sites (Figure S2H) under the 288 
growth conditions of our experiments. Curiously, the polypeptide expressed from 289 
the rpnE iTIS is 98% identical to the product of the ypaA gene (Figure S2I), 290 
revealing a possible distinct functionality of the alternative products of the rpn gene 291 
family.  292 
 293 
5’-proximal iTIS gene may generate differentially-targeted proteins 294 
The speA gene encodes arginine decarboxylase (SpeA), an enzyme 295 
involved in polyamine production (Michael, 2016). SpeA has been found in the E. 296 
coli cytoplasmic and periplasmic fractions (Buch and Boyle, 1985) and was 297 
reported to be represented by two polypeptide isoforms, SpeA-74, with an 298 
apparent MW of 74 kDa, and a smaller one of ~ 70 kDa, SpeA-70, suggested to 299 
be a co-secretional maturation product of the full-length SpeA-74 (Buch and Boyle, 300 
1985; Wu and Morris, 1973). Our analysis, however, revealed two Ribo-RET peaks 301 
in the speA ORF: one corresponding to the annotated pTIS and the second one 302 
mapped to an iTIS at codon Met-26 (Figure S3A). Initiation of translation at the 303 
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pTIS and iTIS of speA would generate the 73,767 Da and 71,062 Da forms of 304 
SpeA, respectively, arguing that the SpeA-70 isoform is generated due to initiation 305 
of translation at the speA iTIS. In support of this conclusion, the peptide 306 
(M)SSQEASKMLR, which precisely corresponds to the N-terminus of the short 307 
SpeA isoform defined by Ribo-RET, can be found in the database of the 308 
experimentally-identified E. coli N-terminal peptides (Bienvenut et al., 2015).  309 
It was suggested that SpeA-74 is targeted to the periplasm due to the 310 
presence of a putative N-terminal secretion signal sequence (Buch and Boyle, 311 
1985). A segment of this signal sequence would be missing in the SpeA-70 isoform 312 
confining the shorter polypeptide to the cytoplasm (Figure S3B). Therefore, 313 
utilization of the 5’-proximal iTIS of speA could change compartmentalization of 314 
the encoded protein. The 5’-proximal iTISs identified in some other E. coli genes 315 
encoding secreted proteins (e.g. bamA, ivy or yghG), may serve similar (Figure 316 
S3C). Analogous strategy for targeting polypeptide isoforms to different cellular 317 
compartments has been described for few other bacterial proteins (reviewed in 318 
(Meydan et al., 2018)).  319 
Six of the 5’-proximal iTISs (marked by asterisks in Figure 3B) were 320 
detected by TET Ribo-seq and suggested to represent incorrectly annotated pTISs 321 
(Nakahigashi et al., 2016). Lack of the Ribo-RET peaks at the annotated pTIS of 322 
some of these genes (Table S1) is generally consistent with this proposal 323 
suggesting that assignment of the pTISs could be reassessed. However, such 324 
conclusion should be drawn cautiously because the utilization of the upstream 325 
pTIS could depend on growth conditions. 326 
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 327 
Conservation analysis of in-frame iTISs 328 
We analyzed alignments of bacterial genes homologous to the E. coli genes 329 
where internal in-frame start sites were detected by Ribo-RET. Sequence logos 330 
and codon conservation plots indicated preservation of in-frame potential initiation 331 
sites and locally enhanced synonymous site conservation at phoH, speA, yebG, 332 
yfaD and yadD (Figure S4A-S4E). However, it remains to be seen whether these 333 
conserved regions are relevant to promoting iTIS usage or simply represent 334 
unrelated sequence requirements of these genes. The other iTISs identified by 335 
Ribo-RET in the E. coli genome show a lower degree of evolutionary conservation 336 
indicating that many of them could be species- or strain-specific.  337 
 338 
Ribo-RET identified iTISs that are out of frame relative to the main ORF 339 
Only two examples of a bacterial ORF nested in an alternative frame within another 340 
ORF had been previously described: comS within srfAB in B. subtilis and rpmH 341 
within rnpA in Thermus thermophilus (reviewed in (Meydan et al., 2018)). Our 342 
Ribo-RET analysis showed the presence of 74 OOF iTISs common between the 343 
examined E. coli BW25113 and BL21 strains. (Figure S5A). The location of the 344 
OOF iTISs within the host genes varies significantly; the peptides generated by 345 
translation initiated at the OOF iTISs would range in size from 2 to 84 amino acids 346 
(Figures 4A, S5A and S5B).  347 
We tested two OOF iTIS candidates (found within the birA and sfsA genes) 348 
for their ability to direct initiation of translation. Initiation of translation at the OOF 349 
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UUG internal start site (overlapping the birA gene Leu300 codon) would yield a 5-350 
amino acid long peptide, while translation initiated at the OOF AUG of the sfsA 351 
gene (overlapping the Leu95 codon of the main ORF) would generate a 12 amino 352 
acid peptide (Figure 4B). When the full-size sfsA and birA genes were translated 353 
in vitro, addition of RET resulted in the appearance of toeprint bands not only at 354 
the pTISs of the corresponding genes (Figure S5C and S5D) but also at the OOF 355 
iTIS start codons (Figures 4C, lanes ‘RET’, orange dots). The addition of the 356 
translation termination inhibitor Api137 (Florin et al., 2017) to the reactions 357 
generated toeprint bands at the stop codons of the OOF ORFs, indicating that the 358 
ribosomes not only bind to the OOF start sites but do translate the entire alternative 359 
ORFs (Figure 4C, lanes ‘API’, magenta triangles).  360 
We then examined whether the alternative ORF in the sfsA gene is 361 
translated in vivo. For this purpose, we engineered a dual RFP/GFP reporter, 362 
where translation of the gfp gene is initiated at the sfsA OOF iTIS (Figure 4D). E. 363 
coli cells carrying such reporter construct actively expressed the GFP protein 364 
(Figure 4D, right panel), whereas gfp expression was abolished when the internal 365 
AUG start codon was mutated to UCG (Figure 4D). This result demonstrates that 366 
the OOF iTIS in sfsA is utilized for initiation of translation in the E. coli. 367 
An independent validation of the functional significance of one of the Ribo-368 
RET identified OOF iTISs came from a recent study aimed at characterizing E. coli 369 
proteins activated by heat-shock (Yuan et al., 2018). In that work, the sequence of 370 
one of the identified tryptic peptides mapped to the -1 frame of the gnd gene, 371 
although the location of the start codon from which translation of the alternative 372 
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protein (named GndA) would initiate remained ambiguous (Yuan et al., 2018). Our 373 
Ribo-RET data not only validated those findings, but also suggested that 374 
translation of GndA initiates most likely at the UUG codon, which is preceded by a 375 
strong SD sequence (Figure 4E).  376 
Expression of functional alternative proteins may be highly specialized 377 
since most of the OOF iTISs identified in the E. coli genome are not conserved. 378 
The strongest example that exhibits near-threshold significance of the OOF iTIS 379 
conservation is that of the tonB gene (Figure S4F). Furthermore, the internal 380 
initiation at this site is apparently sufficiently strong to be observed as an upshift of 381 
the local ribosome density in the Ribo-seq data collected from E. coli cells not 382 
treated with RET (Figure S4F). 383 
 384 
Start-Stop sites may modulate translation of the primary gene 385 
Among the 74 OOF iTIS candidates, Ribo-RET revealed 14 unique sites 386 
where the start codon is immediately followed by a stop codon, and thus we called 387 
them start-stops (Table S1). Although start-stops have been identified in the 5’ 388 
UTRs of some viral and plant genes where they likely play regulatory functions 389 
(Krummheuer et al., 2007; Tanaka et al., 2016), operational start-stops have not 390 
been reported within the bacterial genes. 391 
We selected the identified start-stops within two genes, yecJ and hslR 392 
(Figure 5A), for further analysis. Consistently, in vitro studies, carried out using the 393 
full-length yecJ or hslR genes, showed that in both cases addition of initiation 394 
inhibitor RET or termination inhibitor Api137 caused the appearance of 395 
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coincidental toeprint bands (either one of the inhibitors is expected to stall the 396 
ribosome at the initiation codon of the start-stop site) (Figure 5B). Thus, the iTISs 397 
of the start-stops nested in yecJ and hslR genes can direct ribosome binding. For 398 
in vivo analysis we fused the gfp reporter gene, devoid of its own start codon, 399 
immediately downstream from the AUG codon of the yecJ iTIS (stripped from its 400 
associated stop codon) (Figure 5C). GFP fluorescence derived from the resulting 401 
construct was readily detectable as long as the initiator codon of the start-stop site 402 
was intact, but was significantly reduced when this AUG codon was mutated to 403 
ACG (Figure 5C). These results demonstrated that the start codon of the yecJ 404 
start-stop site is operational in vivo.  405 
We surmised that functional OOF start-stops may carry out regulatory 406 
functions, possibly affecting the expression efficiency of the protein encoded in the 407 
main ORF. To test this hypothesis, we examined whether the presence of a 408 
functional start-stop affects the expression of the main ORF that hosts it. For that, 409 
we prepared a reporter construct where the gfp coding sequence was placed 410 
downstream of the yecJ start-stop but in frame with the yecJ pTIS (Figure 5D). 411 
Mutational analysis verified that expression of the YecJ-GFP fusion protein was 412 
directed by the yecJ pTIS (Figure 5D, wt vs. pTIS(-) bars). Notably, when the start 413 
codon of the OOF start-stop was inactivated by mutation, the efficiency of 414 
expression of the YecJ-GFP reporter increased by approximately 16% (Figure 5D, 415 
wt vs. iTIS(-) bars). These results demonstrate that the presence of the active start-416 
stop site within the yecJ gene attenuates translation of the main ORF, indicative of 417 
its possible regulatory function.  418 
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Interestingly, mutating the stop codon of the yecJ start-stop, that should 419 
lead to translation of a 14-codon internal ORF originating at the yecJ OFF iTIS, 420 
significantly reduced the expression of the YecJ-GFP reporter by ~ 3-fold (the 421 
iSTOP(-) construct in Figure 5D). This result shows that active utilization of some 422 
of the OOF iTISs could significantly attenuate the expression of the main ORF 423 
whereas the position of the corresponding stop codon could modulate this effect. 424 
 425 
Ribo-RET reveals TISs outside of the known annotated coding 426 
sequences 427 
The ability of Ribo-RET to reveal the cryptic sites of translation initiation 428 
makes it a useful tool for identifying such sites located not only within the genes, 429 
but outside of the annotated protein coding regions. We have detected 6 upstream 430 
in-frame TISs (uTISs) in the E. coli strain BW25113 and 36 uTISs in the BL21 431 
strain that would result in N-terminal extensions of the encoded proteins (Table 432 
S2). For one gene (potB), we did not observe any Ribo-RET peak at the annotated 433 
pTIS (Figure S6A), suggesting that either its start site has been mis-annotated or 434 
that the annotated pTIS is activated under growth conditions different from those 435 
used in our experiments. For several other genes (e.g. yifN), we detected Ribo-436 
RET signals for both the annotated pTIS and the uTIS, indicating that two isoforms 437 
may be expressed (Figure S6B).  438 
We also detected 41 TISs, common between the two analyzed strains, 439 
outside of the annotated genes likely delineating the translation start sites of 440 
unannotated short ORFs (Table S2) (analyzed in detail in another study (Weaver, 441 
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2019)). Although analysis of such ORFs was beyond the scope of our work, the 442 
ability to detect such ORFs underscores the utility of Ribo-RET as a general tool 443 
for the genome-wide identification of translation start sites in bacteria.  444 
 445 
DISCUSSION 446 
Genome-wide survey of TISs in two E. coli strains revealed translation 447 
initiation not only at the known start codons of the annotated genes, but also int eh 448 
intergenic regions and, importantly, at over 100 mRNA sites nested within the 449 
currently recognized ORFs. Proteins, whose synthesis is initiated as such sites, 450 
may constitute a previously obscure fraction of the proteome and may play 451 
important roles in cell physiology. In addition, initiation of translation at internal 452 
codons may play regulatory role by influencing the efficiency of expression of the 453 
main protein product. 454 
Mapping of the cryptic translation start sites was possible due to the action 455 
of RET as a highly-specific inhibitor of translation initiation, arresting ribosomes at 456 
the mRNA start codons. It is this specificity of RET action that makes it possible to 457 
utilize the antibiotic for confidently charting not only the TISs at the beginning of 458 
the protein-coding sequences and also for mapping initiation-competent codons 459 
within the ORFs. Other antibiotics that exclusively bind to the initiating ribosomes, 460 
could also be explored for mapping TISs in bacteria (Weaver, 2019). 461 
Our experiments were confined to the E. coli strains. However, we expect 462 
that the drug would exhibit a similar mode of action in other bacterial species. RET 463 
has limited activity against Gram-negative species, partly due to the active efflux 464 
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of the drug (Jones et al., 2006). Therefore, in our experiments with we needed to 465 
use the E. coli strains lacking the TolC component of the multi-drug efflux pumps. 466 
Newer broad-spectrum pleuromutilins (Paukner and Riedl, 2017), could be likely 467 
used even more efficiently for mapping TISs in both Gram-positive and Gram-468 
negative bacterial species.  469 
Ribo-RET revealed the presence of internal start codons in over a hundred 470 
E. coli genes, dramatically expanding the number of putative cases of internal 471 
initiation in bacteria of which, before this work, only a few examples had been 472 
known (Meydan et al., 2018). Our findings suggest that inner-ORF initiation of 473 
translation is a much more widespread phenomenon. Although in most cases we 474 
have little knowledge about the possible functions of the alternative polypeptides 475 
encoded in the bacterial genes, one can envision several general scenarios:  476 
1) In-frame internal initiation generates a protein isoform with a distinct 477 
function. One such example is the ArcB-C polypeptide expressed from the iTIS 478 
within the arcB gene.  479 
2) The isoform expressed from an in-frame iTIS could partake in the hetero-480 
complex formation with the main protein (reviewed in (Meydan et al., 2018)). 481 
Primary proteins encoded by some of the iTIS-containing E. coli genes (e.g. slyB, 482 
nudF, lysU and wzzB) are known to form homodimers and thus, could be 483 
candidates for the formation of heterodimers with their N-terminally truncated 484 
isoforms.  485 
3) Translation from the in-frame 5’-proximal iTIS (e.g. speA, bamA, ivy or 486 
yghG) can alter proteins compartmentalization. Similarly, some of the iTISs 487 
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identified in eukaryotic mRNAs and attributed to the ‘leaky scanning’ may alter the 488 
subcellular localization of the alternative polypeptides (Kochetov, 2008; Lee et al., 489 
2012). 490 
4) Because protein stability significantly depends on the nature of the N-491 
terminal amino acid (Dougan et al., 2010), utilization of an alternative start site may 492 
alter the protein’s half-life.  493 
5) The utilization of the OOF iTISs may generate polypeptides with structure 494 
and function unrelated to those of the main protein.  495 
The significance of some of the cryptic initiation sites, particularly the OOF 496 
iTISs, may reside in their regulatory role. In particular, the discovered start-stop 497 
sites within the E. coli genes may be utilized by the cell for fine-tuning the 498 
expression of proteins encoded in the host ORFs. However, such possible 499 
mechanism is likely subtle, because no significant change in the ribosome density 500 
before and after the start-stop site in the Ribo-seq data collected with the untreated 501 
cells during fast-growth was observed.  502 
It is also likely that not all of the Ribo-RET-identified iTISs directly benefit 503 
bacterial cell and a number of them could simply represent unavoidable noise of 504 
imprecise start codon recognition by the ribosome. Furthermore, Ribo-RET peak 505 
shows only the potential of a codon to be used as a translation start site: by 506 
arresting the ribosomes at a pTIS while allowing the elongating ribosomes to run 507 
off the mRNAs, RET treatment leads to the generation of ribosome-free mRNAs, 508 
thereby allowing ribosome binding to the newly exposed putative iTISs. 509 
Nevertheless, several lines of evidence argue that many of the Ribo-RET-identified 510 
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iTISs are recognized by the ribosomes even in the untreated cells: i) for some 511 
genes (e.g. arcB) an increase in ribosome density downstream of the identified 512 
iTIS can be seen in the Ribo-seq data collected with the untreated cells; ii) we have 513 
experimentally demonstrated the functionality of iTISs in several genes (e.g. arcB, 514 
sfsA); iii) the expression of an OOF ORF within the gnd gene was confirmed by 515 
proteomics (Yuan et al., 2018). 516 
The mechanisms that control the relative utilization of pTISs and iTISs could 517 
operate at the level of translation, via modulating the activity of pTIS and iTIS, or 518 
at the level of transcription: some of the experimentally-mapped transcription sites 519 
map reside between the pTIS and iTIS in some genes (see Table S1).  520 
Besides iTISs, our Ribo-RET data revealed a number of the translation 521 
initiation sites outside of the annotated genes. Most of those sites delineate 522 
previously uncharacterized short genes. Proteins encoded in such ORFs may 523 
further expand the cryptic bacterial proteome (Storz et al., 2014; Weaver, 2019), 524 
whereas translation of the other ORFs could play regulatory roles. 525 
In conclusion, by mapping translation initiation landscape in bacteria Ribo-526 
RET unveils the hidden fraction of the bacterial proteome and offers insights into 527 
gene regulatory mechanisms.  528 
 529 
ACKNOWLEDGEMENTS 530 
We thank T. Florin for help with Ribo-seq experiments, G. Storz, J. Weaver 531 
and A. Buskirk for sharing their unpublished results and useful suggestions 532 
regarding the manuscript, J.E. Barrick for providing the pRXG plasmid, D. 533 
   24 
 
Georgellis for advice with some experiments, Y. Polikanov and N. Aleksashin for 534 
help with some figures. This work was supported by the grant from the National 535 
Science Foundation MCB 1615851 (to ASM and NV-L). PVB is supported by SFI-536 
HRB-Wellcome Trust Biomedical Research Partnership, grant no. 210692/Z/18/Z. 537 
AEF is supported by Wellcome Trust grant no. 106207. 538 
 539 
AUTHOR CONTRIBUTIONS 540 
Conceptualization: S.M., J.M., N.V.-L., and A.S.M.; Methodology: S.M., 541 
N.V.-L., and A.S.M.; Software and formal analysis: J.M., V.S., P.V.B., A.E.F., T.M., 542 
and A.K.; Investigation: S.M. and D.K., Writing: S.M., N.V.-L., and A.S.M.; 543 
Supervision, Project Administration and Funding Acquisition: N.V.-L., and A.S.M. 544 
 545 
DECLARATIONS OF INTEREST 546 
The authors declare no competing interests. 547 
  548 
   25 
 
REFERENCES 549 
 550 
Alvarez, A.F., Barba-Ostria, C., Silva-Jimenez, H., and Georgellis, D. (2016). 551 
Organization and mode of action of two component system signaling circuits 552 
from the various kingdoms of life. Environ. Microbiol. 18, 3210-3226. 553 
Alvarez, A.F., and Georgellis, D. (2010). In vitro and in vivo analysis of the ArcB/A 554 
redox signaling pathway. Methods Enzymol. 471, 205-228. 555 
Atkins, J.F., Loughran, G., Bhatt, P.R., Firth, A.E., and Baranov, P.V. (2016). 556 
Ribosomal frameshifting and transcriptional slippage: From genetic 557 
steganography and cryptography to adventitious use. Nucleic Acids Res. 44, 558 
7007-7078. 559 
Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, 560 
K.A., Tomita, M., Wanner, B.L., and Mori, H. (2006). Construction of 561 
Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio 562 
collection. Mol. Syst. Biol. 2, 2006 0008. 563 
Baek, J., Lee, J., Yoon, K., and Lee, H. (2017). Identification of unannotated small 564 
genes in Salmonella. G3 (Bethesda) 7, 983-989. 565 
Baranov, P.V., Atkins, J.F., and Yordanova, M.M. (2015). Augmented genetic 566 
decoding: global, local and temporal alterations of decoding processes and 567 
codon meaning. Nat. Rev. Genet. 16, 517-529. 568 
Becker, A.H., Oh, E., Weissman, J.S., Kramer, G., and Bukau, B. (2013). Selective 569 
ribosome profiling as a tool for studying the interaction of chaperones and 570 
targeting factors with nascent polypeptide chains and ribosomes. Nat. Protoc. 571 
8, 2212-2239. 572 
Bienvenut, W.V., Giglione, C., and Meinnel, T. (2015). Proteome-wide analysis of 573 
the amino terminal status of Escherichia coli proteins at the steady-state and 574 
upon deformylation inhibition. Proteomics 15, 2503-2518. 575 
Broome-Smith, J.K., Edelman, A., Yousif, S., and Spratt, B.G. (1985). The 576 
nucleotide sequences of the ponA and ponB genes encoding penicillin-binding 577 
protein 1A and 1B of Escherichia coli K12. Eur. J. Biochem. 147, 437-446. 578 
Buch, J.K., and Boyle, S.M. (1985). Biosynthetic arginine decarboxylase in 579 
Escherichia coli is synthesized as a precursor and located in the cell envelope. 580 
J. Bacteriol. 163, 522-527. 581 
Chengguang, H., Sabatini, P., Brandi, L., Giuliodori, A.M., Pon, C.L., and Gualerzi, 582 
C.O. (2017). Ribosomal selection of mRNAs with degenerate initiation triplets. 583 
Nucleic Acids Res. 45, 7309-7325. 584 
Cundliffe, E. (1981). Antibiotic Inhibitors of Ribosome Function. In The Molecular 585 
Basis of Antibiotic Action, E.F. Gale, E. Cundliffe, P.E. Reynolds, M.H. 586 
Richmond, and M.J. Waring, eds. (London, New York, Sydney, Toronto: John 587 
Willey & Sons), pp. 402-545. 588 
D'Souza, C., Nakano, M.M., and Zuber, P. (1994). Identification of comS, a gene 589 
of the srfA operon that regulates the establishment of genetic competence in 590 
Bacillus subtilis. Proc. Natl. Acad. Sci. USA 91, 9397-9401. 591 
Datsenko, K.A., and Wanner, B.L. (2000). One-step inactivation of chromosomal 592 
genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 593 
97, 6640-6645. 594 
   26 
 
Davidovich, C., Bashan, A., Auerbach-Nevo, T., Yaggie, R.D., Gontarek, R.R., and 595 
Yonath, A. (2007). Induced-fit tightens pleuromutilins binding to ribosomes and 596 
remote interactions enable their selectivity. Proc. Natl. Acad. Sci. USA 104, 597 
4291-4296. 598 
Dornhelm, P., and Hogenauer, G. (1978). The effects of tiamulin, a semisynthetic 599 
pleuromutilin derivative, on bacterial polypeptide chain initiation. Eur. J. 600 
Biochem. 91, 465-473. 601 
Dougan, D.A., Truscott, K.N., and Zeth, K. (2010). The bacterial N-end rule 602 
pathway: expect the unexpected. Mol. Microbiol. 76, 545-558. 603 
Feltens, R., Gossringer, M., Willkomm, D.K., Urlaub, H., and Hartmann, R.K. 604 
(2003a). An unusual mechanism of bacterial gene expression revealed for the 605 
RNase P protein of Thermus strains. Proc. Natl. Acad. Sci. USA 100, 5724-606 
5729. 607 
Firth, A.E. (2014). Mapping overlapping functional elements embedded within the 608 
protein-coding regions of RNA viruses. Nucleic Acids Res. 42, 12425-12439. 609 
Florin, T., Maracci, C., Graf, M., Karki, P., Klepacki, D., Berninghausen, O., 610 
Beckmann, R., Vazquez-Laslop, N., Wilson, D.N., Rodnina, M.V., Mankin, A. 611 
S. (2017). An antimicrobial peptide that inhibits translation by trapping release 612 
factors on the ribosome. Nat. Struct. Mol. Biol. 24, 752-757. 613 
Fritsch, C., Herrmann, A., Nothnagel, M., Szafranski, K., Huse, K., Schumann, F., 614 
Schreiber, S., Platzer, M., Krawczak, M., Hampe, J., Brosch, M. (2012). 615 
Genome-wide search for novel human uORFs and N-terminal protein 616 
extensions using ribosomal footprinting. Genome Res. 22, 2208-2218. 617 
Gao, T., Yang, Z., Wang, Y., and Jing, L. (2010). Identifying translation initiation 618 
sites in prokaryotes using support vector machine. J. Theor. Biol. 262, 644-649. 619 
Gao, X., Wan, J., Liu, B., Ma, M., Shen, B., and Qian, S.B. (2015). Quantitative 620 
profiling of initiating ribosomes in vivo. Nat. Methods 12, 147-153. 621 
Gibson, D.G., Young, L., Chuang, R.Y., Venter, J.C., Hutchison, C.A., 3rd, and 622 
Smith, H.O. (2009). Enzymatic assembly of DNA molecules up to several 623 
hundred kilobases. Nat. Methods 6, 343-345. 624 
Giess, A., Jonckheere, V., Ndah, E., Chyzynska, K., Van Damme, P., and Valen, 625 
E. (2017). Ribosome signatures aid bacterial translation initiation site 626 
identification. BMC Biol. 15, 76. 627 
Grenier, F., Matteau, D., Baby, V., and Rodrigue, S. (2014). Complete Genome 628 
Sequence of Escherichia coli BW25113. Genome Announc. 2, e01038-14. 629 
Hartz, D., McPheeters, D.S., Traut, R., and Gold, L. (1988). Extension inhibition 630 
analysis of translation initiation complexes. Methods Enzymol. 164, 419-425. 631 
Hecht, A., Glasgow, J., Jaschke, P.R., Bawazer, L.A., Munson, M.S., Cochran, 632 
J.R., Endy, D., and Salit, M. (2017). Measurements of translation initiation from 633 
all 64 codons in E. coli. Nucleic Acids Res. 45, 3615-3626. 634 
Huerta-Cepas, J., Serra, F., and Bork, P. (2016). ETE 3: reconstruction, analysis, 635 
and visualization of phylogenomic data. Mol. Biol. Evol. 33, 1635-1638. 636 
Impens, F., Rolhion, N., Radoshevich, L., Becavin, C., Duval, M., Mellin, J., Garcia 637 
Del Portillo, F., Pucciarelli, M.G., Williams, A.H., and Cossart, P. (2017). N-638 
terminomics identifies Prli42 as a membrane miniprotein conserved in 639 
   27 
 
Firmicutes and critical for stressosome activation in Listeria monocytogenes. 640 
Nat. Microbiol. 2, 17005. 641 
Ingolia, N.T., Ghaemmaghami, S., Newman, J.R., and Weissman, J.S. (2009). 642 
Genome-wide analysis in vivo of translation with nucleotide resolution using 643 
ribosome profiling. Science 324, 218-223. 644 
Ingolia, N.T., Lareau, L.F., and Weissman, J.S. (2011). Ribosome profiling of 645 
mouse embryonic stem cells reveals the complexity and dynamics of 646 
mammalian proteomes. Cell 147, 789-802. 647 
Jones, R.N., Fritsche, T.R., Sader, H.S., and Ross, J.E. (2006). Activity of 648 
retapamulin (SB-275833), a novel pleuromutilin, against selected resistant 649 
gram-positive cocci. Antimicrob. Agents Chemother. 50, 2583-2586. 650 
Kannan, K., Kanabar, P., Schryer, D., Florin, T., Oh, E., Bahroos, N., Tenson, T., 651 
Weissman, J.S., and Mankin, A.S. (2014). The general mode of translation 652 
inhibition by macrolide antibiotics. Proc. Natl. Acad. Sci. USA 111, 15958-653 
15963. 654 
Kingston, A.W., Ponkratz, C., and Raleigh, E.A. (2017). Rpn (YhgA-Like) Proteins 655 
of Escherichia coli K-12 and their contribution to RecA-independent horizontal 656 
transfer. J. Bacteriol. 199, e00787-16 657 
Kochetov, A.V. (2008). Alternative translation start sites and hidden coding 658 
potential of eukaryotic mRNAs. Bioessays 30, 683-691. 659 
Krummheuer, J., Johnson, A.T., Hauber, I., Kammler, S., Anderson, J.L., Hauber, 660 
J., Purcell, D.F., and Schaal, H. (2007). A minimal uORF within the HIV-1 vpu 661 
leader allows efficient translation initiation at the downstream env AUG. 662 
Virology 363, 261-271. 663 
Lee, S., Liu, B., Lee, S., Huang, S.X., Shen, B., and Qian, S.B. (2012). Global 664 
mapping of translation initiation sites in mammalian cells at single-nucleotide 665 
resolution. Proc. Natl. Acad. Sci. USA 109, E2424-2432. 666 
Li, G.W., Burkhardt, D., Gross, C., and Weissman, J.S. (2014). Quantifying 667 
absolute protein synthesis rates reveals principles underlying allocation of 668 
cellular resources. Cell 157, 624-635. 669 
Makita, Y., de Hoon, M.J., and Danchin, A. (2007). Hon-yaku: a biology-driven 670 
Bayesian methodology for identifying translation initiation sites in prokaryotes. 671 
BMC Bioinformatics 8, 47. 672 
Marks, J., Kannan, K., Roncase, E.J., Klepacki, D., Kefi, A., Orelle, C., Vazquez-673 
Laslop, N., and Mankin, A.S. (2016). Context-specific inhibition of translation 674 
by ribosomal antibiotics targeting the peptidyl transferase center. Proc. Natl. 675 
Acad. Sci. USA 113, 12150-12155. 676 
Meydan, S., Vazquez-Laslop, N., and Mankin, A.S. (2018). Genes within genes in 677 
bacterial genomes. In Regulating with RNA in Bacteria and Archaea, G. Storz, 678 
and K. Papenfort, eds. (Washington, DC: ASM Press ) pp.133-154).  679 
Michael, A.J. (2016). Biosynthesis of polyamines and polyamine-containing 680 
molecules. Biochem. J. 473, 2315-2329. 681 
Miller, M.J., and Wahba, A.J. (1973). Chain initiation factor 2. Purification and 682 
properties of two species from Escherichia coli MRE 600. J. Biol. Chem. 248, 683 
1084-1090. 684 
   28 
 
Nakahigashi, K., Takai, Y., Kimura, M., Abe, N., Nakayashiki, T., Shiwa, Y., 685 
Yoshikawa, H., Wanner, B.L., Ishihama, Y., and Mori, H. (2016). 686 
Comprehensive identification of translation start sites by tetracycline-inhibited 687 
ribosome profiling. DNA Res. 23, 193-201. 688 
Nakatogawa, H., and Ito, K. (2002). The ribosomal exit tunnel functions as a 689 
discriminating gate. Cell 108, 629-636. 690 
Notredame, C., Higgins, D.G., and Heringa, J. (2000). T-Coffee: A novel method 691 
for fast and accurate multiple sequence alignment. J. Mol. Biol. 302, 205-217. 692 
Orelle, C., Carlson, S., Kaushal, B., Almutairi, M.M., Liu, H., Ochabowicz, A., 693 
Quan, S., Pham, V.C., Squires, C.L., Murphy, B.T., Mankin, A. S. (2013). Tools 694 
for characterizing bacterial protein synthesis inhibitors. Antimicrob. Agents 695 
Chemother. 57, 5994-6004. 696 
Park, S.K., Kim, K.I., Woo, K.M., Seol, J.H., Tanaka, K., Ichihara, A., Ha, D.B., and 697 
Chung, C.H. (1993). Site-directed mutagenesis of the dual translational 698 
initiation sites of the clpB gene of Escherichia coli and characterization of its 699 
gene products. J. Biol. Chem. 268, 20170-20174. 700 
Paukner, S., and Riedl, R. (2017). Pleuromutilins: potent drugs for resistant bugs-701 
mode of action and resistance. Cold Spring Harb. Perspect. Med. 7, a027110. 702 
Plumbridge, J.A., Deville, F., Sacerdot, C., Petersen, H.S. A. , Cenatiempo, Y., 703 
Cozzone, A., Grunberg-Manago, M., and Hershey, J.W. (1985). Two 704 
translational initiation sites in the infB gene are used to express initiation factor 705 
IF2 alpha and IF2 beta in Escherichia coli. EMBO J. 4, 223-229. 706 
Poulsen, S.M., Karlsson, M., Johansson, L.B., and Vester, B. (2001). The 707 
pleuromutilin drugs tiamulin and valnemulin bind to the RNA at the peptidyl 708 
transferase centre on the ribosome. Mol. Microbiol. 41, 1091-1099. 709 
Salmon, K.A., Hung, S.P., Steffen, N.R., Krupp, R., Baldi, P., Hatfield, G.W., and 710 
Gunsalus, R.P. (2005). Global gene expression profiling in Escherichia coli 711 
K12: effects of oxygen availability and ArcA. J. Biol. Chem. 280, 15084-15096. 712 
Salzberg, S.L., Delcher, A.L., Kasif, S., and White, O. (1998). Microbial gene 713 
identification using interpolated Markov models. Nucleic Acids Res. 26, 544-714 
548. 715 
Schlunzen, F., Pyetan, E., Fucini, P., Yonath, A., and Harms, J.M. (2004). 716 
Inhibition of peptide bond formation by pleuromutilins: the structure of the 50S 717 
ribosomal subunit from Deinococcus radiodurans in complex with tiamulin. Mol. 718 
Microbiol. 54, 1287-1294. 719 
Shimizu, Y., Inoue, A., Tomari, Y., Suzuki, T., Yokogawa, T., Nishikawa, K., and 720 
Ueda, T. (2001). Cell-free translation reconstituted with purified components. 721 
Nat. Biotechnol. 19, 751-755. 722 
Sievers, F., Wilm, A., Dineen, D., Gibson, T.J., Karplus, K., Li, W., Lopez, R., 723 
McWilliam, H., Remmert, M., Söding, J., et al. (2011). Fast, scalable generation 724 
of high-quality protein multiple sequence alignments using Clustal Omega. Mol. 725 
Syst. Biol. 7, 539. 726 
Storz, G., Wolf, Y.I., and Ramamurthi, K.S. (2014). Small proteins can no longer 727 
be ignored. Annual Review Biochem. 83, 753-777. 728 
Studier, F.W., Daegelen, P., Lenski, R.E., Maslov, S., and Kim, J.F. (2009). 729 
Understanding the differences between genome sequences of Escherichia coli 730 
   29 
 
B strains REL606 and BL21(DE3) and comparison of the E. coli B and K-12 731 
genomes. J. Mol. Biol. 394, 653-680. 732 
Tanaka, M., Sotta, N., Yamazumi, Y., Yamashita, Y., Miwa, K., Murota, K., Chiba, 733 
Y., Hirai, M.Y., Akiyama, T., Onouchi, H., Naito, S., Fujiwara, T. (2016). The 734 
Minimum Open Reading Frame, AUG-Stop, Induces Boron-Dependent 735 
Ribosome Stalling and mRNA Degradation. Plant Cell 28, 2830-2849. 736 
Weaver, J.S., Mohammad, F., Buskirk, Al., Storz, G. (2019). Identifying small 737 
proteins by ribosome profiling with stalled initiation complexes. mBio, in press. 738 
Wilson, D., Pethica, R., Zhou, Y., Talbot, C., Vogel, C., Madera, M., Chothia, C., 739 
and Gough, J. (2009). SUPERFAMILY-sophisticated comparative genomics, 740 
data mining, visualization and phylogeny. Nucleic Acids Res. 37, D380-386. 741 
Wistrand, M., and Sonnhammer, E.L. (2005). Improved profile HMM performance 742 
by assessment of critical algorithmic features in SAM and HMMER. BMC 743 
Bioinformatics 6, 99. 744 
Wu, W.H., and Morris, D.R. (1973). Biosynthetic arginine decarboxylase from 745 
Escherichia coli. Purification and properties. J. Biol. Chem. 248, 1687-1695. 746 
Yan, K., Madden, L., Choudhry, A.E., Voigt, C.S., Copeland, R.A., and Gontarek, 747 
R.R. (2006). Biochemical characterization of the interactions of the novel 748 
pleuromutilin derivative retapamulin with bacterial ribosomes. Antimicrob. 749 
Agents Chemother. 50, 3875-3881. 750 
Yuan, P., D'Lima, N.G., and Slavoff, S.A. (2018). Comparative membrane 751 
proteomics reveals a nonannotated E. coli heat shock protein. Biochemistry 57, 752 
56-60. 753 
Zhou, J., and Rudd, K.E. (2013). EcoGene 3.0. Nucleic Acids Res. 41, D613-624. 754 
 755 
 756 
 757 
  758 
   30 
 
MAIN FIGURE TITLES AND LEGENDS  759 
Figure 1 RET specifically arrests ribosomes at translation initiation sites 760 
(A) Toeprinting analysis showing retapamulin (RET) (triangles)- and tetracycline 761 
(TET) (circles)- induced translation arrest sites during cell-free translation of two 762 
model E. coli genes. ‘C’ and ‘G’ indicate sequencing lanes. Nucleotide and 763 
encoded amino acid sequences are shown.   764 
(B) Metagene analysis plot representing normalized average relative density reads 765 
in the vicinity of the annotated start codons of the genes of E. coli cells treated or 766 
not with RET.  767 
(C) Ribosome footprints density within the spc operon in cells treated or not with 768 
RET. 769 
See also Figures S1.  770 
 771 
Figure 2 Ribo-RET reveals the presence of iTISs in many bacterial genes 772 
(A)  Examples of Ribo-RET profiles of E. coli genes with newly detected iTISs. The 773 
annotated pTISs are marked with green flags and stop codons are shown with red 774 
stop signs; orange flags show the iTISs. iTIS start codons are highlighted in orange 775 
and the SD-like sequences are underlined.  776 
(B) Ribo-RET profiles of infB, clpB, mrcB, the three E. coli genes where iTISs had 777 
been previously characterized.  778 
(C)  The iTISs common between the E. coli BW25113 and BL21 strains. ND (not 779 
determined): the internal Ribo-RET peaks not associated with the known start 780 
codons.  781 
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See also Table S1. 782 
 783 
Figure 3 In-frame internal initiation can generate functional N-terminally 784 
truncated proteins  785 
(A)  The frequency of various putative start codons at the in-frame iTISs. (B) The 786 
relative length of the predicted alternative proteins, products of internal initiation, 787 
in comparison with the main protein. The known examples of genes with in-frame 788 
iTISs (Figure 2B) are in orange. The genes with the iTISs located within the 3’ or 789 
5’ quartile of the gene length are boxed in yellow or blue, respectively. Asterisks 790 
show genes with pTIS re-annotation proposed based on TET-assisted Ribo-seq, 791 
(Nakahigashi et al., 2016). Arrows point at arcB and speA genes further analyzed 792 
in this work. 793 
(C) Ribo-RET profile of arcB showing ribosomal density peaks at the pTIS (green 794 
flag) and the iTIS (orange flag). 795 
(D) Schematics of the functional domains of ArcB. The putative alternative ArcB-C 796 
protein would encompass the phosphotransfer domain.  797 
(E) Western blot analysis of the C-terminally 3XFLAG-tagged translation products 798 
of the arcB gene expressed from a plasmid in E. coli cells. Inactivation of iTIS by 799 
the indicated mutations (mut) abrogates production of ArcB-C. Lane M: 800 
individually-expressed marker protein ArcB-C-3XFLAG (see STAR Methods). 801 
(F) Functional iTIS in arcB facilitates growth under low oxygen conditions. 802 
BW25113 'arcB E. coli cells, expressing from a plasmid either wt arcB or mutant 803 
arcB with inactivated iTIS, were co-grown in low oxygen conditions and the ratio 804 
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of mutant to wt cells was analyzed (see Start Methods for details).  Error bars 805 
represent deviation from the mean (n=2).    806 
(G) The phosphorelay across the wt ArcB domains results in the activation of the 807 
response regulator ArcA (Alvarez et al., 2016). Diffusible ArcB-C could amplify the 808 
signal capabilities of the ArcBA system and/or enable cross-talk with other 809 
response regulators.  810 
See also Figure S2. 811 
 812 
Figure 4 OOF iTISs revealed by Ribo-RET can direct initiation of translation 813 
(A) The length and location of the alternative OOF protein-coding segments 814 
relative to the main ORF.  815 
(B) Ribo-RET profiles of birA and sfsA genes with putative OOF iTISs. The iTIS 816 
OOF start codon and the corresponding stop codon are indicated by orange flag 817 
and stop sign, respectively. The sequences of the alternative ORFs are shown.  818 
(C) Toeprinting analysis reveals that RET arrests ribosomes at the start codons 819 
(orange circles) of the alternative ORFs within the birA and sfsA genes; termination 820 
inhibitor Api137 arrests translation at the stop codons (purple arrowheads) of those 821 
ORFs. The nucleotide and amino acid sequences of the alternative ORFs are 822 
shown. Sequencing lanes are indicated.  823 
(D) In the cell, translation is initiated at the sfsA OOF iTIS. Schematics of the 824 
RFP/sfGFP reporter plasmid. The rfp and sf-gfp genes are co-transcribed. The 825 
sfGFP-coding sequence is expressed from the iTIS (orange flag) and is OOF 826 
relative to the sfsA pTIS start codon (green flag). The first stop codon in-frame with 827 
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the pTIS (red) and the stop codon in-frame with the iTIS (orange) are indicated. 828 
The bar graph shows the change in relative green fluorescence in response to the 829 
iTIS start codon mutation (mut). The values represent the mean ± standard 830 
deviation from technical replicates (n=6). Two-tailed unpaired t-test.  831 
(E) Ribo-RET snapshots of the gnd gene revealing the putative location of the start 832 
codon of the alternative ORF. The amino acid sequence of the alternative ORF 833 
product GndA is shown in orange; the tryptic peptide identified by mass 834 
spectrometry (Yuan et al., 2018) is underlined.  835 
See also Figure S5 and Table S1. 836 
 837 
Figure 5 Start-Stops within E. coli genes  838 
(A) Representative Ribo-RET profiles revealing start-stops. The SD-like 839 
sequences are underlined.  840 
(B) Toeprinting analysis shows ribosomes stalled at the start codons of the start-841 
stop sites in response to the presence of initiation (RET) and termination (API) 842 
inhibitors. The start and stop codons of the start-stop sites are indicated by orange 843 
and purple characters, respectively.  844 
(C) The start codon of the yecJ start-stop can direct initiation of translation in vivo. 845 
sfGFP expression in the RFP/sfGFP reporter is directed by the start codon of the 846 
yecJ start-stop (orange flag). The relative translation efficiency was estimated by 847 
measuring GFP/RFP/OD (%) ratio. The expression of sf-gfp is severely abrogated 848 
by a mutation that disrupts the start-stop initiation codon [iTIS (-)]. The values 849 
   34 
 
represent the standard deviation from the mean in technical replicates (n=3). Two-850 
tailed unpaired t-test. 851 
 852 
(D) Start-stop impacts expression of the yecJ gene. The expression of the YecJ-853 
GFP chimeric protein is controlled by yecJ pTIS (green flag) (gfp sequence is in 0-854 
frame relative to pTIS). The reporter expression increases by ~16% when the start 855 
codon of the start-stop site is disrupted by a mutation [(iTIS(-)]. Mutating the stop 856 
codon of the start-stop site expands the length of the translated OOF coding 857 
sequence and results in severe inhibition of the main frame translation. The error 858 
bars represent standard deviation from the mean in technical triplicates (n=3).  859 
Two-tailed unpaired t-test. 860 
 861 
See also Figure S5 and Table S2.  862 
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STAR METHODS 863 
 864 
Bacterial strains 865 
Ribo-seq experiments were performed in two E. coli strains: the K12-type strain 866 
BW25113 (lacIq, rrnBT14, 'lacZWJ16, hsdR514, 'araBADAH33, 'rhaBADLD78) that 867 
was further rendered 'tolC (called previously BWDK Kannan, 2012 #81}) and the 868 
B-type strain, BL21, (F-, ompT, gal, dcm, lon, hsdSB(rB-mB-)[malB+]K-12 (OS) and 869 
was also rendered 'tolC by recombineering (Datsenko and Wanner, 2000). For 870 
that, the kanamycin resistance cassette was PCR-amplified from BW25113 871 
tolC::kan strain from the Keio collection (Baba et al., 2006) using the primers #P1 872 
and P2 (Table S3). The PCR fragment was transformed into BL21 cells (NEB, 873 
#C2530H) carrying the Red recombinase expressing plasmid pKD46. After 874 
selection and verification of the BL21 tolC::kan clone, the kanamycin resistance 875 
marker was eliminated as previously described (Datsenko and Wanner, 2000). In 876 
the subsequent sections of STAR Methods we will refer to BW25113('tolC) 877 
strain as ‘K’ strain and to BL21('tolC) as ‘B’ strain.   878 
Reporter plasmids were expressed in the E. coli strain JM109 879 
(endA1, recA1, gyrA96, thi, hsdR17 (rk–, mk+), relA1, supE44, Δ(lac-proAB), 880 
[F´ traD36, proAB, laqIqZΔM15]) (Promega, #P9751). 881 
 882 
Metabolic labeling of proteins 883 
Inhibition of protein synthesis by RET was analyzed by metabolic labeling. 884 
Specifically, the B strain cells were grown overnight at 37°C in M9 minimal medium 885 
supplemented with 0.003 mM thiamine and 40 μg/mL of all 19 amino acids except 886 
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methionine (M9AA-Met). Cells were diluted 1:200 into fresh M9AA-Met medium 887 
and grown at 37°C until the culture density reached A600~0.2. Subsequent 888 
operations were performed at 37°C. The aliquots of cell culture (28 µL) were 889 
transferred to Eppendorf tubes that contained dried-down RET (Sigma-Aldrich, 890 
#CDS023386). The final RET concentration ranged from 1x MIC to 32x MIC (0.06 891 
μg/mL to 2 μg/mL). After incubating cells with antibiotic for 3 min, the content was 892 
transferred to another tube containing 2 µL M9AA-Met medium supplemented with 893 
0.3 μCi of L-[35S]-methionine (specific activity 1,175 Ci/mmol) (MP Biomedicals). 894 
After 1 min incubation, 30 µL of 5% trichloracetic acid (TCA) was added to the 895 
cultures and this mixture was pipetted onto 35 mm 3MM paper discs (Whatman, 896 
Cat. No. 1030-025) pre-wetted with 25 µL of 5% TCA. The discs were then placed 897 
in a beaker with 500 mL 5% TCA and boiled for 5 min. TCA was discarded and 898 
this step was repeated one more time. Discs were rinsed in acetone, air-dried and 899 
placed in scintillation vials. After addition of 5 ml of scintillation cocktail (Perkin 900 
Elmer, Ultima Gold, #6013321) the amount of retained radioactivity was measured 901 
in a Scintillation Counter (Beckman, LS 6000). The data obtained from RET-902 
treated cells were normalized to the no-drug control.   903 
The time course of inhibition of protein synthesis by RET was monitored 904 
following essentially the same procedure except that antibiotic was added to a tube 905 
with the cells and 28 µL aliquots were withdrawn after specified time and added to 906 
tubes containing 2 µL M9AA-Met medium supplemented with 0.3 μCi of L-[35S]-907 
methionine. The rest of the steps were as described above.  908 
 909 
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Ribo-seq experiments 910 
The Ribo-seq experiments were carried out following previously described 911 
procedures (Becker et al., 2013). The overnight cultures of E. coli grown in LB 912 
medium at 37°C were diluted to A600~0.02 in 100 mL of fresh LB media sterilized 913 
by filtration and supplemented with 0.2% glucose. The cultures were grown at 37°C 914 
with vigorous shaking to A600~0.5. RET was added to the final concentration of 915 
100X MIC (12.5 μg/mL for the K strain or 5 μg/mL for the B strain) and incubated 916 
for 5 min (K strain) or 2 min (B strain). No antibiotic was added to the control no-917 
drug cultures. Cells were harvested by rapid filtration, frozen in liquid nitrogen, 918 
cryo-lysed in 650 µL of buffer containing 20 mM Tris-HCl, pH 8.0, 10 mM MgCl2, 919 
100 mM NH4Cl, 5 mM CaCl2, 0.4% Triton X100, 0.1% NP-40 and supplemented 920 
with 65 U RNase-free DNase I (Roche, #04716728001), 208 U SUPERasexInTm 921 
RNase inhibitor (Invitrogen, #AM2694) and GMPPNP (Sigma-Aldrich, #G0635) to 922 
the final concentration of 3 mM. After clarifying the lysate by centrifugation at 923 
20,000 g for 10 min at 4°C samples were subjected to treatment with ~450 U 924 
MNase (Roche, #10107921001) per 25 A260 of the cells for 60 min. The reactions 925 
were stopped by addition of EGTA to the final concentration of 5 mM and the 926 
monosome peak was isolated by sucrose gradient centrifugation. RNA was 927 
extracted and run on a 15% denaturing polyacrylamide gel. RNA fragments 928 
ranging in size from ~28 to 45 nt were excised from the gel, eluted and used for 929 
library preparation as previously described (Becker et al., 2013). Resulting Ribo-930 
seq data was analyzed using the GALAXY pipeline (Kannan et al., 2014). The 931 
reference genome sequences U00096.3 (BW25113, ‘K’ strain) and CP001509.3 932 
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(BL21, ‘B’ strain) were used to map the Ribo-seq reads. The first position of the P-933 
site codon was assigned by counting 15 nucleotides from the 3’ end of the Ribo-934 
seq reads. The Ribo-seq datasets were deposited under accession number 935 
GSE1221129.  936 
 937 
Metagene analysis 938 
The genes with the read counts t100 in both control and RET-treated samples 939 
were used for metagene analysis of K and B strains. The published tetracycline 940 
Ribo-seq data (Nakahigashi et al., 2016) were used to generate the corresponding 941 
metagene plot. The genes separated by less than 50 bp from the nearest 942 
neighboring gene were not included in the metagene analysis in order to avoid the 943 
‘overlapping genes’ effects.  944 
For every nucleotide of a gene, normalized reads were calculated by 945 
dividing reads per million (rpm) values assigned to a nucleotide by the total rpm 946 
count for the entire gene including 30 nt flanking regions. The metagene plot was 947 
generated by averaging the normalized reads for the region spanning 10 nt 948 
upstream and 50 nucleotides downstream of the first nucleotide of the start codon. 949 
 950 
Computational identification of translation initiation sites 951 
The assignment of RET peaks to the start codons was performed using the 952 
algorithm provided in Supplemental Information. Specifically, we searched for a 953 
possible start codon (AUG, GUG, CUG, UUG, AUU, AUC) within 3 nucleotides 954 
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upstream or downstream of the Ribo-RET peak. All other codons associated with 955 
an internal RET peak were considered as “non-start” codons (Table S1).  956 
For assessing whether Ribo-RET peaks in K strain match the annotated 957 
start codons in the genes expressed under no-drug conditions, we calculated the 958 
percentage of genes whose rpkm values were t100 in the no-drug conditions and 959 
whose corresponding pTIS Ribo-RET peak values were >1 rpm. More stringent 960 
criteria were used for identification of alternative Ribo-RET peaks (rpm >5).  If the 961 
Ribo-RET peak matched an annotated TIS, it was classified as pTIS (Classification 962 
I, Scheme I and Table S1). “Tailing peaks” (peaks within 10 nt downstream and 963 
upstream of the start codon) around the pTIS were considered as “near-annotated 964 
TIS” and merged with the pTISs after removing duplicates. All pTISs prior to 965 
duplicate removal are provided in Table S1 (the ‘pTISs’ tabs). The Ribo-RET peaks 966 
within coding regions were considered in Classification II and were assigned as in-967 
frame or out-of-frame iTISs depending on the position of the likely start codon 968 
(Table S1, the ‘iTISs’ tabs). Finally, the RET peaks outside of the coding regions 969 
were considered either as N-terminal extensions or unannotated ORFs 970 
(Classification III and Table S2). The criteria for each classification are detailed in 971 
Schemes I, II and III in Supplementary Information.  972 
 973 
Construction of ArcB-expressing plasmids 974 
The plasmids carrying the wt arcB gene (pArcB) or its mutant variant pArcB(mut) 975 
(G1947A, G1950A, G1959C) were generated by Gibson assembly (Gibson et al., 976 
2009). The PCR-generated fragments covering the length of wt or mutant arcB 977 
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genes or of the ArcB-C coding arcB segment were introduced into NcoI and 978 
HindIII-cut pTrc99A plasmid. Three PCR fragments used for the assembly of wt 979 
arcB plasmid were generated by using primer pairs P3/P4, P5/P6 and P7/P8 980 
(Table S3). To construct the pArcB(mut) plasmid, the PCR fragments were 981 
generated by using primer pairs P3/P9, P7/P8 and P10/P11. The plasmid pArcB-982 
C expressing exclusively C-terminal domain of ArcB was prepared by acquiring 983 
the ArcB-C coding sequence as a gBlock (fragment #12 in Table S3) an 984 
dintroducing it into NcoI and HindIII-cut pTrc99A plasmid. All the plasmids were 985 
verified by Sanger sequencing of the inserts. The plasmids were introduced in the 986 
E. coli BW25113 or BW25113('arcB) strains. 987 
 988 
Western blot analysis of the FLAG-tagged ArcB 989 
The BW25113 cells carrying either pArcB or pARcB(mut) plasmids (or the pArcB-990 
C plasmid encoding the marker ArcB-C segment of ArcB) were grown overnight at 991 
37°C in LB medium supplemented with ampicillin (final concentration of 50 μg/mL). 992 
The cultures were diluted 1:100 into 5 mL LB/ampicillin medium supplemented with 993 
0.01 mM of isopropyl-β-D-1-thiogalactopyranoside (IPTG) and grown at 37°C until 994 
culture density reached A600~0.5. The cultures were harvested by centrifugation. 995 
Cells were resuspended in 300 μL of B-PER™ Bacterial Protein Extraction 996 
Reagent (Thermo Fisher, #78248) and centrifuged at 16,000 g for 10 min. Ten μL 997 
of the cell lysate were loaded on TGX 4-20% gradient gel (Bio-Rad, #4561096). 998 
Resolved proteins were transferred to a PVDF membrane using PVDF transfer 999 
pack (Bio-Rad, #1704156) by electroblotting (Bio-Rad Trans-Blot SD Semi-Dry 1000 
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Transfer Cell, 10 min at 25 V). Membrane was blocked by incubating in TBST (50 1001 
mM M Tris [pH 7.4], 150 mM NaCl, and 0.05% Tween-20) containing 5% non-fat 1002 
dry milk and probed with Anti-FLAG M2-Peroxidase (Sigma-Aldrich, #A8592) and 1003 
anti-GAPDH antibodies (Thermo Fisher, #MA5-15738-HRP) at 1:1000 dilution in 1004 
TBST. The blot was developed using Clarity Western ECL Substrate (Bio-Rad, 1005 
#170-5060) and visualized (Protein Simple, FluorChem R). 1006 
 1007 
Growth competition under low oxygen conditions of cells expressing wild 1008 
type or mutant arcB genes. 1009 
Dependence of micro-aerobic cell growth on expression of arcB was initially 1010 
verified by co-growing E. coli BW25113('arcB) cells transformed with the empty 1011 
vector pTrc99A or the vector carrying wt arcB gene (pArcB). Overnight cultures, 1012 
grown in LB medium supplemented with 100 µg/mL of ampicillin, were diluted 1013 
1:100 into fresh LB supplemented with 100 µg/mL of ampicillin and 10 µM of IPTG, 1014 
grown to A600~0.5 and mixed in the proportion to provide equal number of pTrc99A- 1015 
and pArcB cells. Plasmids from the mixed “0 passage” sample were isolated and 1016 
stored. The 0 passage mix culture was diluted 1:1000 into two 14 ml culture tubes 1017 
containing each 12.5 ml of fresh LB/amplicillin/IPTG medium. Tubes were tightly 1018 
capped and grown vertically with no shaking at 37°C. Cell sedimentation was 1019 
avoided by the slow rotation (~ 40 rpm) of a small magnet placed at the bottom of 1020 
the tubes. After 24 h, cultures were diluted 1:1000 into tubes with fresh medium, 1021 
while the rest of the cells were used for isolation of the total plasmid (“passage 1” 1022 
sample). The same procedure was carried out for two more passages (passage 2 1023 
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and 3). To assess the relative representation of cells with pTrc99A or pArcB the 1024 
total plasmid from each of the passages 0-3 was linearized with HindIII. The 4176 1025 
bp pTrc99A DNA and 6570 bp pArcB DNA bands were resolved by agarose 1026 
electrophoresis (Figure S2C). 1027 
This same low-oxygen experimental set-up was used for the growth competition 1028 
of BW25113('arcB) cells expressing wt or mutant arcB, from pArcB or pArcB(mut), 1029 
respectively. In this case, 5 passages were performed (passages 0-5) and, instead 1030 
of isolating plasmids from the cultures, cells from 500 µL aliquots of passages 0, 1031 
2, 3, 4, and 5 were collected and stored. After completing the passages, cells were 1032 
resuspended in 200 µL H2O, boiled for 10 min to lyse the cells and 1 µL of the 1033 
lysate was used to PCR-amplify the segment of the arcB gene encompassing the 1034 
iTIS region (primers P52 and P53, Table S3). The resulting PCR fragments were 1035 
purified and subjected to capillary sequencing. The ratio of cells carrying wt and 1036 
mutant arcB (that carried the G1947A, G1950A, G1959C mutations) genes was 1037 
estimated by comparing the height of the sequencing peaks corresponding to the 1038 
position G1959C.  1039 
 1040 
Toeprinting assay 1041 
The DNA templates for toeprinting, were prepared by PCR amplification for the 1042 
respective genes from the E. coli BW25113 genomic DNA. The following primer 1043 
pairs were used for amplification of specific genes: atpB: P13/P14; mqo: P15/P16; 1044 
birA: P18/P19; hslR: P30/P31; yecJ: P33/P34. Two point mutations were 1045 
generated in sfsA in order to change the stop codon of the alternative ORF from 1046 
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TGA to TAG because in the PURE transcription-translation system, the termination 1047 
inhibitor Api137 arrest termination at the TAG stop codon with a higher efficiency 1048 
(Florin et al., 2017). This was achieved by first amplifying segments of the sfsA 1049 
gene using pairs of primers P22/P23 and P24/P25 and then assembling the entire 1050 
mutant sfsA sequence by mixing the PCR products together and re-amplifying 1051 
using primers P26/P27. Toeprinting primer P17 was used with the atpB and mqo 1052 
templates. Primers P20, P28, P32 and P36 were used for analysis of ribosome 1053 
arrest at pTIS of birA, sfsA, hslR and yecJ templates, respectively.  Primers P21, 1054 
P29, P33 and P37 were used for the analysis of ribosome arrest at the iTISs of 1055 
birA, sfsA, hslR and yecJ templates, respectively. 1056 
Transcription-translation was performed in 5 µL reactions of the PURExpress 1057 
system (New England Biolabs, #E6800S) for 30 min at 37°C as previously 1058 
described (Orelle et al., 2013). Final concentration of RET, tetracycline (Fisher 1059 
scientific, #BP912-100) or Api137 (synthesized by NovoPro Biosciences, Inc.) was 1060 
50 μM. The primer extension products were resolved on 6% sequencing gels. Gels 1061 
were dried, exposed overnight to phosphorimager screens and scanned on a 1062 
Typhoon Trio phosphorimager (GE Healthcare). 1063 
 1064 
Polysome analysis  1065 
For the analysis of the mechanism of RET action, the overnight culture of the K 1066 
strain was diluted 1:200 in 100 mL of LB medium supplemented with 0.2% glucose. 1067 
The culture was grown at 37°C with vigorous shaking to A600 ~0.4 at which point 1068 
RET was added to the final concentration of 100X MIC (12.5 µg/mL) (control 1069 
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culture was left without antibiotic). After incubation for 5 min at 37°C with shaking, 1070 
cultures were transferred to pre-warmed 50 mL tubes and cells were pelleted by 1071 
centrifugation in a pre-warmed 37°C Beckman JA-25 rotor at 8,000 rpm for 5 min. 1072 
Pellets were resuspended in 500 µL of cold lysis buffer (20mM Tris-HCl, pH7.5, 15 1073 
mM MgCl2), transferred to an Eppendorf tube and frozen in a dry ice/ethanol bath. 1074 
Tubes were then thawed in an ice-cold water bath and 50 µL of freshly prepared 1075 
lysozyme (10 mg/ml) was added. Freezing/thawing cycle was repeated two more 1076 
times. Lysis was completed by addition of 15 µL of 10% sodium deoxycholate 1077 
(Sigma, #D6750) and 2 µL (2U) of RQ1 RNase-free DNase (Promega, #M610A) 1078 
followed by incubation on ice for 3 min. Lysates were clarified by centrifugation in 1079 
a table-top centrifuge at 20,000 g for 15 min at 4°C. Three A260 of the lysate were 1080 
loaded on 11 ml of 10%-40% sucrose gradient in buffer 20 mM Tris-HCl, pH 7.5, 1081 
10mM MgCl2, 100 mM NH4Cl2, 2 mM E-mercaptoethanol. Gradients were 1082 
centrifuged for 2 h in a Beckman SW-41 rotor at 39,000 rpm at 4°C. Sucrose 1083 
gradients were fractionated using Piston Gradient Fractionator (Biocomp).   1084 
 1085 
Construction of the reporter plasmids 1086 
The RFP/GFP plasmids were derived from the pRXG plasmid, kindly provided by 1087 
Dr. Barrick (University of Texas). The vector was first reconstructed by cutting 1088 
pRXG with EcoRI and SalI and re-assembling its backbone with 2 PCR fragments 1089 
amplified from pRXG using primer pairs P38/P39 (rfp gene) and P40/P41 (sf-gfp 1090 
preceded by a SD sequence). The resulting plasmid (pRXGSM), had RFP ORF 1091 
with downstream SpeI sites flanking the SD-containing sf-GFP ORF. To generate 1092 
   45 
 
pRXGSM-sfsA plasmids, sfsA sequences were PCR amplified from E. coli 1093 
BW25113 genomic DNA with primers P42/P43, for the wt gene, or P42/P44, for 1094 
the mutant variant, and assembled with the SpeI-cut pRXGSM plasmid. To 1095 
generate the pRXGSM-yecJ reporter plasmids, the pRXGSM was cut with SpeI 1096 
and assembled with each of the PCR fragments generated using the following 1097 
primer pairs: P45/P46 (iTIS-wt plasmid), P45/P47 (iTIS(-)); P45/P48 (pTIS-wt), 1098 
P45/P50 (pTIS-iTIS(-)). pRXGSM-yecJ-pTIS(-) and pRXGSM-yecJ-pTIS-iStop(-) 1099 
plasmids were generated by site directed mutagenesis of the pRXGSM-yecJ-pTIS-1100 
wt plasmid using primers P49 and P51, respectively. 1101 
 1102 
Fluorescence and cell density measurements 1103 
E. coli JM109 cells carrying the reporter plasmids were grown overnight in LB 1104 
medium supplemented with 50 μg/mL kanamycin (Fisher Scientific, #BP906-5). 1105 
The cultures were then diluted 1:100 into fresh LB medium supplemented with 1106 
kanamycin (50 μg/mL) and grown to A600 ~0.5-0.8. The cultures were diluted to the 1107 
final density of A600 ~0.02 in fresh LB/kanamycin (50 μg/mL) medium 1108 
supplemented with 0.1 mM IPTG and 120 μL were placed in the wells of a clear 1109 
flat bottom 96 well microplate (Corning, #353072). The plates were placed in a 1110 
Tecan Infinite M200 PRO plate reader, where they were incubated at 37°C with 1111 
orbital shaking (duration: 1000 sec; amplitude: 3 mm), and measurements of 1112 
optical density (at 600 nm), ‘green fluorescence’ (excitation: 485 nm; emission: 520 1113 
nm) and ‘red fluorescence’ (excitation: 550 nm and emission: 675 nm) were 1114 
acquired in real time.  1115 
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 1116 
Evolutionary conservation analysis 1117 
Protein sequences of the genes of interest were extracted from Ecogene database 1118 
(Zhou and Rudd, 2013). Homologs for each gene were obtained by performing a 1119 
tblastn search against the nr database. Briefly, the nr database was downloaded 1120 
on 19/01/2018 to a local server and tblastn searches were performed for each 1121 
gene (parameters -num_descriptions 1000000 -num_alignments 1000000 -evalue 1122 
0.0001). Only those tblastn hits which share a sequence identity of at least 45% 1123 
with the query sequence and whose length is at least 75% of the query sequence 1124 
were retained. Hits that contain in-frame stop codons were also discarded. 1125 
Alignments for each gene of interest were generated by first translating the 1126 
nucleotide sequences to protein sequences, aligning the protein sequences using 1127 
Clustal-Omega (Sievers et al., 2011) and then back-translating the aligned protein 1128 
sequence to their corresponding nucleotide sequence using T-coffee (Notredame 1129 
et al., 2000). To analyze the conservation of internal start codons for each 1130 
candidate gene, a 45-nucleotide region containing the internal start codon and 7 1131 
codons on either side of the start codon was extracted from each alignment. 1132 
Sequence logos were built using this region of alignment and visualized to assess 1133 
the conservation of the internal start codon. In order to determine if there is 1134 
purifying selection at synonymous positions in the alignment, Synplot2 was used 1135 
(Firth, 2014). Synplot2 was applied to each alignment (window size – 15 codons) 1136 
and the resulting plots were visualized to assess the degree of synonymous site 1137 
variability in the region of internal start codon. 1138 
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 1139 
Analysis of the conservation of arcB internal start site 1140 
Bacterial orthologs of arcB were retrieved from OrtholugeDB. Coordinates of 1141 
histidine-containing phosphotransfer domain (HPT domain) were determined with 1142 
HMMSEARCH (Wistrand and Sonnhammer, 2005) using the model 0051674 1143 
retrieved from Superfamily database version 1.74 (Wilson et al., 2009). For 1144 
predicting internal initiation site, 40 nt long fragments were extracted containing 12 1145 
codons upstream of the predicted beginning of HPT domain and 1 codon 1146 
downstream. Potential SD-aSD interactions were estimated by scanning the 1147 
fragment with aSD 5'-ACCUCCU-3' using a 'G threshold of -8.5. The presence of 1148 
in-frame initiation codons (AUG, GUG, UUG) was checked. If initiation codon was 1149 
found closer than 15 nt from SD-aSD sequence, the gene was reported to have in-1150 
frame iTIS. After removing redundancy for the strains of the same species, internal 1151 
in-frame iTISs were identified for 26 bacterial species. Maximum Likelihood (ML) 1152 
tree for 26 arcB sequences was computed using ETE command line tools by 1153 
executing the command: “ete3 -w standard_fasttree -a arcB_protein_seq_in.fas -1154 
o ete_output” (Huerta-Cepas et al., 2016). Final figure (Figure S2B) was produced 1155 
with function PhyloTree from ETE3 toolkit (Huerta-Cepas et al., 2016). 1156 
Table S1: List of common and strain-specific iTISs identified by Ribo-RET in the 1157 
E. coli strains BW25113 and BL21, related to Figures 2 and 3. 1158 
 1159 
Table S2: List of common and strain-specific TISs identified by Ribo-RET in the E. 1160 
coli strains BW25113 and BL21 outside of the annotated genes, related to Figure 1161 
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 1163 
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Figure S1 Retapamulin arrests ribosomes at initiation, Related to Figure 1 
(A) The chemical structure of the pleuromutilin antibiotic retapamulin (RET) bound 
at the PTC active site of the bacterial ribosome. The model is based on the 
structural alignment of the 50S ribosomal subunit of Deinococcus radiodurans (Dr) 
ribosomes in complex with RET (PDB 2OGO) (Davidovich et al., 2007) and 
Thermus thermophilus 70S ribosomes with fMet-tRNA bound in the P site and Phe-
tRNA in the A site (PDB 1VY4) (Polikanov et al., 2014). Note that in the 70S 
initiation complex, the fMet moiety of the initiator tRNA has to be displaced from 
the PTC active site to allow for RET binding.  
(B) RET cannot coexist with a nascent protein in the ribosome. Alignment of the 
structures of the Dr 50S RET complex with the E. coli 70S ribosome carrying 
ErmBL nascent peptide that esterifies P-site tRNA (PDB 5JTE) (Arenz et al., 2016). 
(C) Sucrose gradient analysis of polysome preparation from E. coli BW25113 
ΔtolC cells untreated (top) or treated for 5 min with 12.5 µg/mL (100X MIC) RET. 
The shown profiles represent cryo-lyzed preparations used in Ribo-seq 
experiments. Qualitatively similar results have been obtained in analytical 
experiments with the samples prepared by freezing-thawing (see STAR Methods). 
(D) Residual protein synthesis in E. coli BL21 ΔtolC cells treated with RET, as 
estimated by incorporation of [35S]-methionine into the TCA-insoluble protein 
fraction, after 1 min exposure to increasing concentrations of RET (top) or treated 
with 2 µg/mL of RET (32-fold MIC) for the indicated periods of time (bottom).  
(E) Metagene plots comparing the normalized average relative density of 
ribosomal footprints in E. coli BW25113 ΔtolC cells untreated (gray trace) or 
treated 12.5 µg/mL (100X MIC) of RET (black trace). Blue trace represents similar 
analysis of the publicly-available Ribo-seq data obtained with E. coli BW25113 
ΔsmpB cells exposed to tetracycline (TET) [the average of two replicates of Ribo-
seq experiments reported in (Nakahigashi et al., 2016)].   
(F) Metagene plots comparing the normalized average relative density of 
ribosomal footprints in the E. coli strains BW25113 ΔtolC cells or E. coli BL21 ΔtolC 
untreated or treated with RET. 
(G) Snapshot of ribosomal footprints density in the secM gene of E. coli BW25113 
ΔtolC cells untreated or treated with RET. The pTIS and stop codon of the gene 
are indicated by a green flag and red stop sign, respectively. The black arrow 
indicates the known site of translation arrest at the codon 165 of the 170-codon 
secM ORF (Nakatogawa and Ito, 2002).  
 
  
 
 
Figure S2 The utilization of an in-frame iTIS within the arcB gene leads to 
production of an alternative protein ArcB-C with a potential role in cell 
physiology, Related to Figure 3 
 (A) The uncropped image of the immunoblot shown in Figure 3E, representing the 
bands corresponding to full-length ArcB-3X FLAG and internal initiation product 
ArcB-C-3XFLAG (marked with arrow heads). Protein size markers are shown. The 
origin of the bands marked with dots is unknown.  
(B)  The iTIS that directs translation of the ArcB-C protein is conserved in the arcB 
gene of diverse bacterial species. The putative start codons and the SD-like 
sequences are shown. 
(C) Presence of arcB facilitates E. coli growth under low oxygen conditions. 
BW25113 DarcB E. coli cells carrying the empty vector pTrc99a or pArcB were co-
grown in low oxygen conditions. Gel shows the HindIII-linearized plasmids, 
isolated from the co-growth cultures to determine fraction of cells with or without 
arcB in the mixture (see Start Methods for details). The ‘’0’ sample represents 
plasmids from the initial mixture containing equal number of pTrc99A and pArcB 
cells. 
(D-G) The upshift of ribosomal footprints in the arcB segment encoding ArcB-C 
observed in the Ribo-seq profiles of untreated E. coli or Salmonella enterica cells 
(Baek et al., 2017; Kannan et al., 2014; Li et al., 2014). The pTIS and iTIS of arcB 
are marked with green and orange flags, respectively, and the stop codon is 
indicated by a red stop sign.  
(G)  Representative examples of Ribo-RET and Ribo-seq profiles of two out of five 
E. coli rpn genes.  
(H)  Alignment of the amino acid sequence of the RpnE-C protein, translated from 
the iTIS within the rpnE gene and the protein encoded in an independent gene 
ypaA. 
 
 
  
 
 
 
 
 
Figure S3. Initiation at the 5’-end proximal iTISs could produce alternative 
products with incomplete N-terminal signal sequences, Related to Figure 4 
 (A)  Ribo-RET profile of the speA gene, showing peaks corresponding to pTIS 
(green flag) and iTIS (orange flag). The stop codon is indicated by a red stop sign. 
The putative signal sequence (indicated by dark blue letters) of SpeA-74 (Buch 
and Boyle, 1985) is lacking in the alternative product SpeA-70 whose translation 
is initiated at the iTIS. The SpeA isoforms, whose translation is initiated at the pTIS 
or the iTIS are expected to have different cellular localization. The peptides 
detected by N-terminomics are boxed (Bienvenut et al., 2015).  
(B)  Ribo-RET profiles of bamA, ivy and yghG genes. The N-terminal amino acid 
sequences of the primary and predicted alternative proteins are indicated. The 
reported signal sequences are shown in dark blue. The pTISs of the genes are 
marked by green flags; iTISs are indicated with orange flags. 
 
 
 
 
 
Figure S4. Synonymous site conservation for selected iTISs, Related to 
Figures 3-5 
(A) Synonymous site conservation plots and weblogos for genes with in-frame 
iTISs (phoH, speA, yfaD, yadD, yebG) and for the tonB gene with an OOF iTIS. 
Alignment gaps in each sequence are indicated in grey. The two panels show the 
synonymous substitution rate in a 15-codon sliding window, relative to the CDS 
average (observed/expected; brown line) and the corresponding statistical 
significance (p-value; red line). The horizontal dashed grey line indicates a p-
value of 0.05 / (CDS length/window size) – an approximate correction for multiple 
testing within a single CDS. 
(B) An upshift in the local density of ribosome footprints within the alternative frame 
defined by the tonB OOF iTIS (orange rectangle) in cells not exposed to antibiotic. 
Start codons of the pTIS and OOF iTIS are marked with green and orange flags, 
respectively, while the respective stop codons are indicated with red and purple 
stop signs. The start codon and SD-like sequence of the iTIS are shown. 
 
  
 
 
 
 
 
 
 
Figure S5 Ribo-RET reveals OOF iTISs, Related to Figures 4 and 5 
(A) The distribution of start codons associated with OOF iTISs revealed by Ribo-
RET. 
(B) The length distribution of the putative alternative proteins whose translation is 
initiated at OOF iTISs. 
(C) and (D) Toe-printing gels showing RET-induced ribosome stalling at the pTISs 
of birA and sfsA (shown in Figure 4) and hslR and yecJ (shown in Figure 5) genes. 
Samples analyzed in the lanes marked NONE contained no antibiotics. Start 
codons of the pTISs are indicated in green. Sequencing lanes are shown.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S6. Examples of the genes with Ribo-RET identified TISs outside of 
the coding regions, Related to Figure 1 
(A) Ribo-RET profile of the potB gene, shows no peak of the ribosome density at 
the start codon of the annotated pTIS (dark green flag), but instead reveals a strong 
peak at an in-frame start codon 27 nt upstream (pale green flag).  
(B) In the yjfN gene, Ribo-RET reveals peak at the annotated pTIS (dark green 
flag) and an additional peak 9 nts upstream from it (marked with a pale green flag). 
The sequences surrounding the two TISs, including the SD-like regions 
(underlines) are shown.  
See Table S2 for other cases of Ribo-RET signals outside of the coding regions.  
 
  
 
 
Supplemental scheme 1: Flow chart showing the criteria used to identify pTISs 
(Classification I), Related to STAR methods 
 
  
 
 
 
Supplemental scheme 2: Flow chart showing the criteria used to identify iTISs 
(Classification II), Related to STAR methods 
 
  
  
 
 
 
Supplemental scheme 3: Flow chart showing the criteria used to identify N-
terminal extensions and un-annotated TISs (Classification III), Related to STAR 
methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S3: List of primers and synthetic DNA fragments used in this study, 
Related to STAR methods 
  
Sequence (5' to 3') Purpose 
P1 TGTCCTGGCACTAATAGTGA Forward primer for amplification 
of tol::kan cassette 
P2 ACGATGCGTGGCGTATGG Reverse primer for amplification 
of tol::kan cassette 
P3 TTGTGAGCGGATAACAATTTCACACAGG
AAACAGACCATGGTGGGTATTATTGGGG
CAGG 
Forward primer for amplification 
of arcB-PCR 1-wt 
P4 ACATAATACTGCGCCAGC Reverse primer for amplification 
of arcB-PCR 1-wt 
P5 AAGCAAATTCGTCTGCTGG Forward primer for amplification 
of arcB-PCR 2-wt 
P6 TGGGAATATCGAGCAATGCTT Reverse primer for amplification 
of arcB-PCR 2-wt 
P7 GAAGAGAACAGTAAATCAGAAGCATTG Forward primer for amplification 
of arcB-PCR 3 
P8 TCAGGCTGAAAATCTTCTCTCATCCGCC
AAAACAGCCAAGCTTTCACTTGTCATCGT
CAT 
Reverse primer for amplification 
of arcB-PCR 3 
P9 TCCTGGGTATCCCAGAATTTC Reverse primer for amplification 
of arcB-PCR 1-mutant 
P10 CGCTAACCGCGATGATCAAGAAATTCTG
GGATACCCAGGATGATGAAGAAAGTACG
GTCACGACAGAAGAG 
Forward primer for amplification 
of arcB-PCR 2-mutant 
P11 TGGGAATATCGAGCAATGCTTCTGATTTA
CTGTTCTCTTCTGTCGTGACCGTACTTTC
TTCATCATCCTGGGTATCCCA 
Reverse primer for amplification 
of arcB-PCR 2-mutant 
#12 AACAGACCATGGTACCCAGGATGATGAG
GAGAGTACGGTGACGACAGAAGAGAAC
AGTAAATCAGAAGCATTGCTCGATATTCC
CATGCTGGAACAGTATCTCGAACTTGTA
GGACCGAAGCTGATCACCGACGGGTTA
GCGGTGTTTGAGAAGATGATGCCGGGCT
ATGTCAGCGTGCTGGAGTCGAATCTGAC
GGCGCAGGATAAAAAAGGCATTGTTGAG
GAAGGACATAAAATTAAAGGTGCGGCGG
GGTCAGTGGGGTTACGCCATCTGCAACA
GCTGGGTCAGCAAATTCAGTCTCCTGAC
CTTCCGGCCTGGGAAGATAACGTCGGTG
AATGGATTGAAGAGATGAAAGAAGAGTG
GCGTCACGACGTAGAAGTGCTGAAAGC
GTGGGTGGCAAAAGCCACTAAAAAAGAC
TACAAAGACCATGACGGTGATTATAAAG
ATCATGACATCGATTACAAGGATGACGA
TGACAAGTGAAAGCTTGGCTGTT 
gBlock for arcB-marker insert 
P13 TAATACGACTCACTATAGGGCTGTAATTA
ACAACAAAGGGT 
Forward primer for amplification 
of atpB 
P14 GGTTATAATGAATTTTGCTTATTAACCGA
GAATGTACGCAGTTAGTCCAGCTGAAGG
TT 
Reverse primer for amplification 
of atpB 
P15 TAATACGACTCACTATAGGGACTAAAAGT
AAGGCATTAAC 
Forward primer for amplification 
of mqo 
P16 GGTTATAATGAATTTTGCTTATTAACCTG
CTCCTCGGACGCTTATTTCGCTTTTGCC
GCC 
Reverse primer for amplification 
of mqo 
P17 GGTTATAATGAATTTTGCTTATTAAC Reverse primer for toeprinting of 
atpB and mqo 
P18 TAATACGACTCACTATAGGGAGCGCAGT
GGAGACA 
Forward primer for amplification 
of birA 
P19 CTACGCAAATAATTTGCAGGG Reverse primer for amplification 
of birA 
P20 TTTCACCCAACTGCTC Reverse primer for toeprinting of 
primary site of birA 
P21 AATACTCCCCTTTCTTATTTTT Reverse primer for toeprinting of 
internal site of birA 
P22 TAATACGACTCACTATAGGGCAATAACAA
GGATTGTCGCAATG 
Forward primer for amplification 
of sfsA-PCR 1 
P23 GCCGTATTTTACTTCGCTTTCTAGCGAGC
TATAGCCTGACAG 
Reverse primer for amplification 
of sfsA-PCR 1 
P24 CTGTCAGGCTATAGCTCGCTAGAAAGCG
AAGTAAAATACGGC 
Forward primer for amplification 
of sfsA-PCR 2 
P25 CTACAATGTAACCGGCAGTG Reverse primer for amplification 
of sfsA-PCR 2 
P26 TAATACGACTCACTATAGGG Forward primer for amplification 
of sfsA-g321a, a322g 
P27 CTACAATGTAACCGGCAGTG Reverse primer for amplification 
of sfsA-g321a, a322g 
P28 CATCGGGTGTGATCAC Reverse primer for toeprinting of 
primary site of sfsA 
P29 CGATTTCACTTCAATATA Reverse primer for toeprinting of 
internal site of sfsA 
P30 TAATACGACTCACTATAGGGGCTAATGT
GAAGGAGACGC 
Forward primer for amplification 
of hslR 
P31 TTATTCACTGTCGCCGTG Reverse primer for amplification 
of hslR 
P32 GGGCCAGCGCGC Reverse primer for toeprinting of 
primary site of hslR 
P33 TTGTCCGGGCGTCGG Reverse primer for toeprinting of 
internal site of hslR 
P34 TAATACGACTCACTATAGGGAATGCTATC
AGGAGTTTACGATG 
Forward primer for amplification 
of yecJ 
P35 TTAATGGGATTCACCCTGTGGG Reverse primer for amplification 
of yecJ 
P36 CATCCAGAATTTGTTTGATAAC Reverse primer for toeprinting of 
primary site of yecJ 
P37 GCGGCGGCGGGATGG Reverse primer for toeprinting of 
internal site of yecJ 
P38 GTGAGCGGATAACAATTTCACACAGAAT
TCATTAAAGAGGAGAAATTAACTATGGCT 
Forward primer for amplification 
of RFP 
P39 ATATCTCCTTCTTAAAGTTAAACAACTAG
TCTATTCGCCAGAACCAGC 
Reverse primer for amplification 
of RFP 
P40 TTTAAGAAGGAGATATACATATGACTAGT
GCATCCAAGGGCGA 
Forward primer for amplification 
of GFP 
P41 TCAGCTAATTAAGCTTGGCTGCAGGTCG
ACCCGGGGTACCGAG 
Reverse primer for amplification 
of GFP 
P42 TCCGCTGCTGGTTCTGGCGAATAGACTA
GTCAATAACAAGGATTGTCGCAATG 
Forward primer for amplification 
of insert for pRXGSM-sfsA-wt 
P43 AAAGAGCTCCTCGCCCTTGGATGCACTA
GTGCGAGCTATAGCCTGAC 
Reverse primer for amplification 
of insert for pRXGSM-sfsA-wt 
P44 AAAGAGCTCCTCGCCCTTGGATGCACTA
GTGCGAGCTATAGCCTGACAGTTCTGAA
ATTGATTCGATAAGGATAGCCT 
Reverse primer for amplification 
of insert for pRXGSM-sfsA-
mutant 
P45 GTTCTGGCGAATAGACTAGTAAATGCTAT
CAGGAGTTTACG 
Forward primer for amplification 
of insert for pRXGSM-yecJ 
derivatives 
P46 AGCTCCTCGCCCTTGGATGCACTAGTCA
TCGAGAACATCCAGAATTTG 
Reverse primer for amplification 
of insert for pRXGSM-yecJ-iTIS-
wt 
P47 AGCTCCTCGCCCTTGGATGCACTAGTCG
TCGAGAACATCCAGAATTTG 
Reverse primer for amplification 
of insert for pRXGSM-yecJ-
iTIS(-) 
P48 AGAGCTCCTCGCCCTTGGATGCACTAGT
TACATCGAGAACATCCAGAATTTG 
Reverse primer for amplification 
of insert for pRXGSM-yecJ-
pTIS-wt 
P49 CTGCTGGTTCTGGCGAATAGACTAGTAA
TGCTATCAAAAGTTTACGTCGTCCCAGC
CGCT 
Primer for site directed 
mutagenesis to generate 
pRXGSM-yecJ-pTIS(-) 
P50 AGCTCCTCGCCCTTGGATGCACTAGTTA
CGTCGAGAACATCCAGAATTTG 
Reverse primer for amplification 
of insert for pRXGSM-yecJ-
pTIS-iTIS(-) 
P51 AGCTCCTCGCCCTTGGATGCACTAGTGA
CATCGAGAACATCCAGAATTTG 
Primer for site directed 
mutagenesis to generate 
pRXGSM-yecJ-pTIS-iStop(-) 
P52 GGCCTTAACCGCTAACGT Direct primer for sequencing the 
iTIS region in the arcB gene 
P53 TTTAATCTGTATCAGGCTGAAAATCTT Reverse primer for sequencing 
the iTIS region in the arcB gene 
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